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ABSTRACT  
 
Characterizing thermodynamics and kinetics of molecular systems is the ultimate goal 
of biophysics. In drug discovery, this information becomes essential. Understanding local 
and global rearrangements, how formation and disruption of biomolecular complexes 
occur, the molecular determinants involved and the preferred pathways followed, 
contribute to forming a solid ground for the development of new drugs. Quantifying 
specific kinetic parameters, such as off rates and the closely related residence time, is 
increasingly being incorporated in the drug optimization phase. Several experimental 
techniques established to study and quantify kinetic features. Conversely, the 
computational counterpart still faces severe challenges, such as accessing the time scales at 
which these slow events occur, while acquiring acceptable statistics. 
During this PhD program, we explored current, state-of-the-art computational 
methods, and combination thereof, to study kinetic properties of pharmaceutically relevant 
biomolecules. In particular, we applied different protocols to three test systems. In the first 
case, we reconstructed the free energy surface of an intrinsically disordered protein and 
calculated interconversion rates between the differently folded states identified. In the 
second application, Markov State Models were employed to identify relevant states along 
the protein-ligand binding pathway. Using these states as a template, a putative pathway on 
which computing the free energy profile associated with the binding process was 
determined. As for the third test case, we performed unbinding simulations on a series of 
ligands and prioritized them according to their average computational unbinding time. The 
obtained ranking was subsequently confirmed by performing experimental assays. 
Despite clear limitations, the picture arising from the studies was encouraging. 
Computer simulations emerged undoubtedly as a valuable instrument for assessing kinetic 
properties of biomolecular systems. Therefore, in light of the rapid advances in computer 
power expected from the upcoming years, their role as effective tools to assist the 
discovery of novel drug-like molecules is extremely promising.  
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1. INTRODUCTION 
 
1.1 Kinetics, besides thermodynamics 
 
Macromolecules are the key characters of the cellular machinery. By taking part in a 
plethora of intricate networks consisting of functional pathways, they ensure the 
subsistence of cell homeostasis. Proteins, in particular, represent the major operative bricks 
on which this complex scheme in constructed. If, on the one hand, the physiological status 
is maintained by the regular activity of macromolecules, on the other hand, pathological 
conditions arise as a result of alterations in these functionalities. Intervening with the aim 
of resolving a pathological state implies a thorough understanding of the molecular basis 
underlying the specific, altered mechanisms. This, in turn, translates to the necessity of a 
detailed characterization of both structural and dynamical features of the biomolecules of 
interest. By investigating thermodynamic properties of biological systems, equilibrium 
populations can be determined. Thus, it is possible to identify the most relevant states in 
which a specific macromolecule can be found, and the relative stabilities can be quantified 
in terms of free energy differences. Most of the scientific work that has been carried out up 
to this date was focused at achieving this static, nevertheless pivotal, description.1 
However, a complete comprehension of the molecular mechanisms is obtained when 
integrating such information with the kinetic counterpart.2 This includes determining the 
time scales at which the events occur, identifying the preferred pathways followed when 
transitioning from one state to another one, and recognizing the slowest, known as rate-
limiting, steps comprised in the mechanism under study. However, achieving these goals is 
complicated by the transient nature of intermediate, elusive states that are difficult to 
observe both through experiments and computer simulations, thus justifying the more 
contained advancements in this prospect. 
In the context of drug discovery, this integral picture becomes the essential ground 
field on which devising strategies and protocols leading to a desired pharmacological 
effect. Once the molecular basis underlying specific physiological and pathological 
conditions is well characterized, rational approaches basing on the available information 
can be developed. Thus, the activity of proteins, such as enzymes or membrane receptors, 
can be modulated to obtain a therapeutic response, or the access to non-physiological states 
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causing the onset of the pathology can be prevented. In the vast majority of cases, this is 
achieved by means of the interaction of small molecules with specific biomolecular targets. 
The ultimate goal then becomes the identification of novel drug-like molecules able to take 
part in the molecular mechanisms of interest producing a desired therapeutic effect.  
 
1.2 On- and off-rates in drug discovery 
 
Current drug discovery and development programs rely on experimental and 
computational supervision. Over the last decades, the advancements in technologies and 
methodologies on both sides have been tremendous. Nevertheless, the invested efforts are 
not balanced by the poor success rate in the identification of novel drugs.3 Most frequently, 
drug-like molecules that appear extremely promising in the early phases of the drug 
discovery pipeline end up being discarded during the subsequent clinical trials. This is 
generally ascribed to insufficient or inappropriate pharmacokinetic qualities, evidences of 
unexpected toxicity, or in vivo inefficacy. In the latter case, the importance of kinetic 
parameters as a measure of the in vivo effect has gradually emerged.4–6 Traditionally, the 
activity of drug-like molecules has been expressed in terms of the equilibrium dissociation 
constant, Kd, or by the half-maximal inhibitory concentration, IC50, both often determined 
under closed in vitro conditions. However, in many cases the correspondence does not 
hold, particularly when the duration of the pharmacological effect is a considerable 
component of the in vivo efficacy. These findings started to shed light on the kinetic 
profiles of the compounds. Thus, there has been a shift of focus in order to include the 
association rate constant, kon, and the dissociation rate constant, koff, in drug discovery 
programs.4 In particular, the aim has become a rational control of such properties during 
the drug optimization phase. 
A fast binding drug, possessing a high on-rate, would be desirable when dealing with a 
short-living biomolecular target, as the chance of encounter is increased.7 Moreover, the 
role of on-kinetics for ligand selectivity has been also outlined in recent studies.8,9 On the 
dissociation side, devising drugs with smaller off-rates is the goal in the vast majority of 
cases. This translates to prolonged occupation of the binding site on a molecular target, 
resulting in extended duration of the effect. The term residence time, expressed as the 
inverse of koff, was coined to designate this concept.10 However, a drastic increase of side 
effects is observed in certain proteins when the residence time is extended. In such 
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circumstances, fast-off rates would be ideal.11 Therefore, while the overall relevance of on- 
and off-rates has been now recognized, it is clear that best kinetic features should be 
identified on a case-by-case basis, depending on the specific macromolecular target of 
interest.  
  
1.3 Gaining insights into biological kinetics via computer 
simulations 
 
Determining thermodynamic properties of biological systems has been a major 
objective of structural biology since the early times. Thus, significant advances have been 
made over the years from both the experimental and computational point of view. As such, 
established methodologies exist nowadays in this respect. Drug discovery has certainly 
gained from these developments. On one hand, understanding mechanisms and structural 
features of relevant macromolecules contributed to creating a solid base for a rational 
approach. On the other hand, striking support for drug discovery and development 
programs was acquired. The recent scientific literature is clearly indicating that the effort 
should now be directed towards kinetics.5,6 Therefore, integrating such information in 
current drug discovery protocols has become rather appealing and undoubtedly promising.  
Experimental methods such as nuclear magnetic resonance (NMR) spectroscopy and 
surface plasmon resonance (SPR) gained considerable popularity in this respect. The 
former proved to be very effective in characterizing highly dynamic systems,12,13 while the 
latter in measuring kinetic quantities.14 However, from the computational standpoint, 
providing insights about kinetic features of biomolecular systems is still extremely 
challenging. A wide configurational space, including relevant transitions along slow 
degrees of freedom demands for both significant computational resources and effective 
strategies to make sampling accessible and efficient. Although techniques to enhance the 
exploration of the phase space can be exploited, time resolution is typically lost. Thus, 
methods to reconstruct information about the timescales need to be subsequently 
integrated.  
In the work carried out during this PhD program, we took advantage of state-of-the-art 
computational methods and combination of these to gain insights into kinetic properties of 
biological systems bearing pharmaceutical relevance. We devised different protocols 
depending on the specific scientific problem to address and on the characteristic of the 
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considered biomolecules. Specifically, three strategies are shown, each one applied to a 
different test case.  
In the first application, we reconstructed the free energy surface (FES) of an 
intrinsically disordered protein15 by taking advantage of enhanced sampling methods.16 
Subsequently, we built a kinetic model basing on the determined free energy to provide 
kinetic information. Thus, besides identifying the differently folded states accessible, we 
were able to compute interconversion rates between these states.  
As for the second test case, Markov State Models (MSM)17 were combined to path 
collective variables18 with the aim of determining the free energy profile associated to a 
protein-ligand binding process. MSM were employed in the initial stage in order to 
identify relevant states along the binding pathway. This information was then used as a 
template on which constructing a putative pathway for the process, as required by the 
implementation of the path collective variables.  
Finally, in the last test case, we carried out unbinding simulations on a protein-ligand 
system. To this end, as reproducing unbinding is a non-trivial task, we exploited an 
enhanced sampling method, namely scaled MD.19,20 A series of small molecules were 
considered and we prioritized them according to their average computational unbinding 
time.21 Subsequently, the obtained ranking was compared to experimental data by carrying 
out experimental assays that allowed evaluating kinetic parameters, achieving a 
satisfactory agreement. 
To provide a general understanding about the employed techniques, we first give some 
theoretical insights about the core concepts. This is illustrated in the next Theory chapter, 
preceded by a short historical contextualization on rate constants. The single applications 
are introduced and discussed separately in the following Results chapter. The discussion is 
then closed with conclusive remarks and perspectives about future directions. 
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2. THEORY 
 
2.1 Kinetics of chemical reactions 
 
The foundation of chemical kinetics can be found in the Arrhenius equation, an 
empirical expression formulated in 1889 by the Swedish scientist. According to this 
equation, the rate constant k of a chemical reaction can be denoted as: 
 𝑘 = 𝐴𝑒%&' ()⁄  (1) 
 
where A is a constant, named the pre-exponential factor, that is characteristic for each 
chemical reaction, Ea is the activation energy, R is the gas constant and T is the 
temperature. The expression was essentially derived to describe the dependence of a rate 
constant on temperature. However, it inherently introduced and highlighted fundamental 
concepts for reaction kinetics. First of all, Arrhenius argued that, for the reaction to take 
place and products to be formed, the reactants need to first gain a certain, minimum 
amount of energy, that he termed the activation energy. Secondly, in order to determine the 
value of the rate, the energetic term is multiplied by a pre-exponential factor, a concept that 
was further elaborated by subsequent theories. 
The collision theory, proposed independently by Trautz in 1916 and by Lewis in 1918, 
was devised to describe chemical reactions between simple species in the gas phase. For a 
bimolecular elementary reaction of the type: 
 𝐴 + 𝐵 → 𝑃 (2) 
 
the velocity of formation of the product P can be calculated as: 
 𝑣 = 𝑘[𝐴][𝐵] (3) 
 
where k is the rate constant associated to the reaction, and [A] and [B] are the molar 
concentrations of the reactants. The central idea behind this theory is that, in order to 
generate products, reactants need to get in touch through collision, and collisions need to 
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be sufficiently energetic. A further complication comes from the relative orientation in 
which reactants need to find themselves for the collision to become effective. In this 
context, the rate can be expressed as: 
 𝑘 = 𝑃𝜎3456)78 𝑁:𝑒%&' ()⁄  (4) 
 
where P is a steric factor accounting for the orientation of the reactants, s is the collision 
cross section, µ is the reduced mass of the reactants, NA is the Avogadro number, Ea is the 
activation energy, and kB, R and T are the Boltzmann constant, the gas constant and the 
temperature, respectively. The equation essentially summarizes the aspects introduced 
above, namely the steric requirement, indicated by the steric factor P, the encounter rate or 
collision frequency, computed through the product 𝜎;(8𝑘>𝑇 𝜋𝜇⁄ )𝑁:, and the minimum 
energy requirement, represented by the exponential incorporating the activation energy Ea. 
Provided that the dependence on temperature prevails in the exponential, compared to the 
non-exponential term representing the encounter rate, the expression has the Arrhenius 
form. Therefore, in this illustration, the pre-exponential factor incorporates the 
requirements for the encounter of the reacting species.  
With the subsequent transition state theory, developed simultaneously in 1935 by 
Eyring and by Evans and Polanyi, the problem was discussed in terms of statistical 
thermodynamics. The theory introduces the idea of a transition state, indicated by C‡:  
 𝐴 + 𝐵 ⇄ 𝐶‡ ⟶ 𝑃 (5) 
 
The transition state is an activated complex in rapid equilibrium with the reactants and 
that turns into the product P by unimolecular reaction. Eyring’s formulation for the rate 
constant associated to the forwards reaction was: 
 𝑘 = 56)G 𝑒%HI‡ ()⁄  (6) 
 
where h is the Plank’s constant, ∆G‡ is the free energy barrier between the reactants 
and the transition state, and kB and T are the Boltzmann constant and the temperature. The 
equation tells that the more energy is necessary to form the transition state C‡, the smaller 
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the value of the exponential and, in turn, of the overall rate of reaction. We can make the 
expression explicit in terms of the corresponding enthalpy (∆H‡) and entropy (∆S‡) 
differences by means of the equality: 
 ∆𝐺‡ = ∆𝐻‡ − 𝑇∆𝑆‡ (7) 
 
Thus obtaining:  
 𝑘 = 56)G 𝑒%∆O‡ ()⁄ 𝑒∆P‡ ()⁄  (8) 
 
It is interesting to discuss the simple example of a unimolecular reaction in the gas 
phase. In this case, it is valid the equivalence: 
 𝐸R = ∆𝐻‡ + 𝑅𝑇 (9) 
 
The above formula can be substituted in equation 8, thus obtaining: 
 𝑘 = 56)G 𝑒T𝑒∆P‡ ()⁄ 𝑒%&' ()⁄  (10) 
 
By isolating the exponential that expresses the dependence on the activation energy Ea, all 
of the remaining terms can be incorporated in the pre-exponential factor. In this view, the 
pre-exponential is a measure of the activation entropy associated to the reaction.  
According to Eyring’s equation, when the reacting chemicals accumulate enough 
energy, they always proceed to formation of the product. However, this is not necessarily 
always correct, and discrepancies with experiments arise. Therefore, to explicitly take into 
account this possibility, the concept of transmission coefficient was formulated. The 
transmission coefficient, expressed as k, is a factor varying from 0 to 1 that indicates the 
fraction of reacting molecules that are in fact converted to product. Eyring’s equation can 
be thus modified accordingly in order to include k:  
 𝑘 = 𝜅 56)G 𝑒%∆I‡ ()⁄  (11) 
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In this expression, the transmission coefficient represents an additional contribution to 
the pre-exponential factor. When k equals 1, the expression corresponds to Eyring’s 
formulation and energy is the only requirement for product formation. Conversely, with a 
value of 0, no product is obtained. What affects the value of k is essentially the nature of 
the local environment in which the reaction takes place. This formulation can be attributed 
to Kramers, that in 1940 presented his interpretation of the transmission coefficient as a 
function of the solvent viscosity.22 Kramers’ theory is based on the Langevin equation that 
describes the motion of a body with mass m along a generic reaction coordinate x as: 
 𝑚WXYWZX = −W[(Y)WY − 𝛾𝑚 WYWZ + 𝑓(𝑡) (12) 
 
Truncating the expression to the first term on the right side of the equivalence returns 
the traditional Netwon’s equation of motion. Under the Langevin regime, Newton’s 
equation is augmented by two additional forces: a friction force, measured by including the 
solvent viscosity g, that dissipates the energy of the body, and a random force, f(t), that acts 
agitating the body in a stochastic manner. Starting from the Langevin equation, Kramers 
carried out elegant mathematical operations to calculate the dependence of a reaction rate 
on g. Without going into further details, we mention that Kramers found two solutions for 
limiting regimes of g, that is very high g, named the Kramers high friction regime, and very 
low g, termed the Kramers low viscosity regime. However, he was not able to find any 
formulation for the rate constant that worked for the full range of g. This point was 
subsequently addressed by Pollak and coworkers.23  
Following the given illustration about rate theories, an increasing level of complexity 
can be observed. Starting from the more general, empiric expression conceived by 
Arrhenius, we arrived at presenting the more complete interpretation given by Kramers. In 
the context of the present thesis, where it comes to dealing with biomolecular systems 
plunged into liquid solvents, Kramers’ theory is undoubtedly more appropriate to achieve a 
better description of the dynamics involved. 
 
2.2 Exploiting computational methods to study kinetic 
properties of biological systems 
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When we talk about kinetics of biological macromolecules, we aim at describing the real 
dynamics of these systems. In other words, one wishes to follow their journey along 
different, possible states that they are able to visit and populate. A transition from an initial 
state to a different one might consist in a conformational change. This would be the case 
when folding or unfolding take place, or when a major structural rearrangement occurs due 
to intrinsic propensity or in response to a trigger event. Another example of transitioning 
between states is represented by ligand binding or unbinding. In this case, the picture is 
complicated by the necessity of different bodies not only to approach, but also to get in 
touch in specific regions of their surfaces, and potentially with specific orientations and 
conformations. A further source of complexity would be a conformational change that 
needs to take place before the final protein-ligand complex can be formed. What is 
common to such plethora of different scenarios is the fact that the events involved can be 
considered very slow in all cases. With slow, we mean that such transitions require 
considerably higher time scales to happen compared to local fluctuations of the atomic 
coordinates. In the best case, experiments succeed at describing and quantifying these 
events at a macroscopic scale. From a computational standpoint, the most appropriate 
technique to follow the dynamics of a macromolecular system over time is Molecular 
Dynamics (MD) simulations.24 However, plain MD does not guarantee the access to these 
timescales that we are usually interested in. First of all, when performing MD, we deal 
with a microscopic representation of the system, and, secondly, the allowed time-
resolution for the dynamics of these microscopic systems is considerably confined. This 
discrepancy is typically referred to as the timescale problem. Consequently, an increasing 
number of approaches have been specifically devised for improving sampling of the 
configurational space and for extracting longer timescales information while exploiting 
achievable computational resources.  
In this section, we provide some theoretical background on methods and combination 
thereof that we employed to study kinetic properties of biologically relevant systems. 
Applications to three specific test cases are then shown in the subsequent Results chapter. 
Briefly, we combined enhanced sampling,16 namely Metadynamics (MetaD),25 with a bin-
based kinetic model26 to determine kinetic rates between differently folded states of an 
intrinsically disordered protein. As for the second test case, a Markov State Model 
(MSM)17 was constructed to identify relevant states along the binding pathway of a 
protein-ligand system. Subsequently, such states were employed to build a guess path on 
which applying the path collective variables (path CVs).18 Thus, information from MSM 
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was integrated with path CVs in order to reconstruct the free energy profile along the 
binding process, in this second example. Finally, unbinding simulations were performed 
for a series of ligands of a test case protein taking advantage of another enhanced sampling 
method, namely scaled molecular dynamics (scaled MD).19,20 
Firstly, we give a basic theoretical overview about these techniques that we took 
advantage of in order to improve the sampling of the configurational space. Secondly, we 
discuss the methods employed to recover kinetic information from the molecular 
simulations.  
 
2.2.1 Sampling the configurational space 
 
As introduced above, due to the timescale problem, we cannot always rely on plain 
MD to adequately sample a configurational space involving slow events. Inspired by this 
necessity, the so-called enhanced sampling methods have been developed.16 As suggested 
by the term, common to this class of techniques, independently from the specific strategy 
underlying, is an improved, still statistically correct, exploration of the configurational 
space. Broadly speaking, we can recognize two major subclasses. On the one side, we have 
methods based on reaction coordinates that describe slow degrees of freedom of the 
system. These reaction coordinates, referred to as collective variables (CVs), are used to 
guide the exploration of the phase space. Approaches such as umbrella sampling,27 steered 
MD28,29 and MetaD25 belong to this class. On the other side, we have non CV-based 
techniques of different flavors, in which sampling is enhanced along all of the degrees of 
freedom of the system. Part of this second class are for instance tempering methods, such 
as parallel tempering (PT),30 and scaled MD.19,20 
In this work, we took advantage of both CV-based and non-CV-based enhanced 
sampling methods. In the following, we provide a brief description of the theory behind the 
techniques that we employed.  
 
2.2.1.1 Metadynamics 
In MetaD,25 we add a history-dependent bias potential along specific reaction 
coordinates of our system, the CVs. These essentially describe slow degrees of freedom of 
the system, that allow guiding sampling towards relevant regions of the phase space. 
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Therefore, by taking advantage of CVs, the exploration of the highly dimensional phase 
space accessible to the system is reduced to a lower dimensional problem. The bias 
potential added through MetaD is expressed by means of the following function: 
 𝑉I(𝑞, 𝑡) = ∑ 𝑊𝑒%de%e(Z)fX ghXiZjk,l,gl,..  (13) 
 
It has the form of a Gaussian possessing width W and height s, which is deposited 
along the CV q at increasing intervals t of the simulation time. The overall bias VG(q,t) 
deposited at time t is then given by the summation over the total amount of Gaussians 
deposited. What happens in practice is that, at time intervals t during the simulation, the 
value of the CV is computed and a small Gaussian deposited on that specific point of the 
CV space. This Gaussian placed has now a repulsive effect, as it discourages the system to 
visit again that region of the CV space, thus exhorting the exploration of non-previously 
visited ones. Therefore, if we start our simulation with the system located inside a certain 
local energy minimum, the bias is going to favor first the exploration of the CV space 
belonging to that basin. As shown in Figure 1, we can look at the bias as if we were 
gradually filling the energy basin.  
 
 
Figure 1. Pictorial representation of the MetaD method. The bias (filled curves from red to light pink) is 
gradually deposited at increasing time intervals t (going from red to light pink) along a CV q. Assuming that 
a simulation is started from inside basin A, the gradual filling due to bias deposition allows crossing the 
barrier and visiting basin B. Accordingly, basin C is eventually sampled. Once all of the relevant minima 
have been visited, the system experiences free diffusion along the reaction coordinate. At that point, minus 
the total bias accumulated gives the free energy.  
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Suppose we are in basin A, at some point this would be filled and the system would 
fall inside basin B, and so on. Once all of the basins are filled, the system is able to freely 
diffuse in the CV space. We can then reconstruct the FES in such CV space as: 
 𝑉I(𝑞, 𝑡 → ∞) = −𝐹(𝑞) (14) 
 
 When employing MetaD, two major drawbacks are encountered: assessing the 
convergence of the simulation and choosing the CVs to bias.31 As for the first one, it is not 
obvious when to stop the simulation. Once all of the basins are visited, and while the 
simulation keeps running, the bias keeps being deposited. This has the effect of overfilling 
the underlying FES and inducing the system to visit high-energy regions of the CVs space. 
Thus, for a reliable FES estimate, the simulation should be stopped as soon as the system 
starts diffusing in the CVs space. However, this is not straightforward to assess. In order to 
overcome this limitation, a variant of MetaD has been introduced, referred to as well-
tempered MetaD.32 While in standard MetaD Gaussians of constant height W are deposited 
over time, in well-tempered MetaD the bias is gradually reduced. As a result, the 
overfilling mentioned above is less pronounced. In this variant of MetaD, Gaussian height 
becomes a function of the simulation time, according to: 
 𝑊(𝑡) = 𝑊k𝑒%pq(e,Z) 56⁄ ∆) (15) 
 
where W0 is the initial Gaussian height, and VG(q,t) is the total bias deposited at time t. In 
the equation, DT represents the upper limit of the temperature range at which the CVs are 
sampled. In regular MetaD, the gradual addition of the potential energy bias in the CV 
space corresponds to sampling along the chosen CVs at increasing temperature values. 
Conversely, in the well-tempered variant, this behavior is confined and the mentioned 
overfilling of energy basins alleviated. 
Each time the system is brought inside a new basin, the initial Gaussian height W0 is 
restored and the simulation time-dependent scaling of the hills restarted. As a result, the 
bias potential tends to smoothly converge in the long time limit. Particular care is 
necessary when deciding the entity of decrease in Gaussian height per time unit. W should 
not become too small before the basin is completely filled, otherwise not enough bias 
would be gathered to overcome the barrier and the system would remain stuck inside the 
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minimum as a result. In the current implementation, this can be controlled by setting for 
the simulation a specific parameter called bias factor, defined as: 
 𝛾 = )r∆))  (16) 
 
where DT is the upper limit of the temperature range to which the sampling of the CVs is 
confined. 
Through this scheme, the potential smoothly converges in the long time limit. 
However, it does not fully correspond to the underlying free energy, as: 
 𝑉I(𝑞) = − ∆))r∆) 𝐹(𝑞) (17) 
 
The second limitation is about the identification of an appropriate set of CVs. As 
already discussed, all of the relevant degrees of freedom of the system need to be taken 
into account by the CVs. If this is not the case, the simulation will not converge and 
pathological behaviors are likely to be observed. Identifying relevant CVs involves 
probably the largest initial effort, and is more a trial and error procedure. Nevertheless, it is 
worth noting that the effort is not completely vain, as much understanding about the 
system under study is typically gained at this stage. In order to reduce the possibility of 
neglecting relevant degrees of freedom, several strategies can be applied. Among those 
relying on the use of CVs, one is using bias-exchange MetaD,33 in which multiple replicas 
of the system are simulated in parallel, and a different CV is biased in each replica. 
Another possibility, specifically devised to manage particularly complex reaction 
pathways, is the use of path CVs. Conversely, the problem can be in part alleviated by 
coupling MetaD with non-CV-based methods, such as parallel tempering.30 In the latter 
case, temperature is exploited to facilitate transitions along all of the degrees of freedom 
that might be neglected by the choice of CVs. 
 
2.2.1.2 Path Collective Variables 
As already widely discussed, plain MD is extremely limited when dealing with rare 
events. Achieving satisfactory sampling for a wide phase space, possibly comprising 
significant energetic barriers, would require an impressive computational effort, if 
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achievable at all. The risk for the system is to station within local energy minima for long 
periods of time, and infrequently crossing barriers in favor of different regions. Obtaining 
proper statistics for the estimation of an accurate FES becomes unfeasible in such a 
scenario. As a result, a plethora of strategies have been devised that enhance sampling and 
thus optimize the computational effort.16 MetaD,25 described in detail, is one of such 
methods and allows an efficient reconstruction of complex FES. However, as already 
discussed, a major limitation of this technique is the initial effort required to identify a 
valid set of CVs to guide sampling.31 On the one hand, the chosen CVs need to take into 
account all of the slow degrees of freedom of the system. If this is not true, then the 
simulation will not converge. On the other hand, the number of CVs must be contained to 
avoid exceedingly slow filling times. Essentially, one needs a reasonable number of 
relevant CVs. This point becomes particularly challenging when it comes to protein-ligand 
binding, as a plethora of slow degrees of freedom can be potentially involved, ranging 
from solute desolvation, conformations of the ligand and rearrangements in protein 
residues. Therefore, with the purpose of overcoming the difficulty of managing highly 
dimensional phase space and reducing human intervention on the choice of the CVs, the 
path CVs formalism has been developed.18  
Let us assume that we have an idea of what happens along a complex reaction, and we 
are able to describe it by means of a putative pathway, which is a series of frames 
capturing the system at intermediate states along the reaction of interest. Then we can 
exploit this frameset to guide sampling along the “guess path” by means of the following 
CVs:  
 𝑠(𝑋) = Tu%T v∑ (w%T)xyzd{y{(|)fX}|~∑ xyzd{y{(|)fX}|~  (18) 
 𝑧(𝑋) = − T ln ∑ 𝑒%d%(w)fXuwjT  (19) 
 
For a certain microscopic configuration X of the system during the MetaD simulation, 
the variable s can range between 0 and P, where P is the number of frames comprised in 
the frameset. The summations run over each frame i in the frameset, and for each of them 
the difference (X-X(i))2 is the distance between the configuration X of the system and the 
one adopted in frame i. Notably, there is no restriction in the distance metric used. 
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However, it is common practice to use the mean square deviation (MSD), resulting in 
squared distance units. This is preferred over the RMSD for numerical reasons, but they 
are conceptually interchangeable. Whenever the microscopic configuration sits on, that is 
corresponds to, a specific frame i, then all of the other terms in the summation disappear 
and s(X) = i. Thus, in practice, s describes the progression along the frameset. As for the 
second parameter, z can be thought as orthogonal to s, and expresses the distance from the 
putative pathway. While we advance along the putative pathway, z allows exploring 
adjacent regions of the phase space. To give a practical illustration, we can imagine the 
configurational space accessible to the system as confined within a cylinder, where the axis 
corresponds to the frameset, and z defines the radius. In the above functions, l is a tunable 
parameter that ensures continuous progression. It is proportional to the inverse of the 
average MSD between subsequent frames in the frameset. As a rule of thumb, the 
following formula has been suggested: 
 𝜆 = g.(u%T)∑ ||%||}y|~  (20) 
 
 In summary, the highly dimensional phase space is reduced to a 2-dimensional 
description exploiting as CVs the progression along a putative pathway. The main 
advantage from combining s to z is a more permissive exploration of the configurational 
space around the guess route. As such, in the reconstructed FES, the minimum free energy 
pathway can be then recognized. 
However, the non-trivial point here is that the overall framework is based on the 
availability of a putative pathway, that is an a priori idea of what is going on along the 
complex reaction. There is no general rule to obtain the required frameset, and the 
feasibility is strictly dependent on the information one can access. Additionally, a valid 
frameset responds to specific requisites. First of all, subsequent frames need to describe 
unidirectional progression towards the final state. No loops leading back and forth should 
be present. Secondly, equal spacing between subsequent frames is required. This is 
expressed in terms of the metric used to parameterize the guess path. Finally, an 
appropriate number of frames should be chosen, so that the distance between subsequent 
frames is not excessive. Indeed, the resolution of the reconstructed FES is going to reflect 
the amplitude of the spacing achieved. 
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2.2.1.3 Parallel Tempering 
As already discussed, several methods have been developed over the years to improve 
sampling of the complex configurational space accessible to molecular systems. While 
techniques based on CVs can be very efficient, they nevertheless require a considerable 
intervention and effort by the user. Indeed, identifying reaction coordinates that represent 
slow degrees of freedom of the system is far from trivial, if achievable at all. Conversely, 
in non CV-based techniques the bias affects the entire system, acting along all of the 
degrees of freedom.  
PT30 belongs to the non-CV-based class of methods. As suggested by the name, N 
replicas of the system are simulated in parallel at increasing temperature values T1, T2, T3, 
… TN. At fixed intervals during the simulation, exchanges of configurations between 
adjacent replicas are attempted. The probability of accepting the exchange responds to the 
Metropolis Monte Carlo Scheme: 
 𝑃(𝑖 → 𝑗) = 𝑚𝑖𝑛1, Δwu) (21) 
 
with: 
 Δwu) =  T56)| − T56) 𝑈(𝑥w) − 𝑈d𝑥f (22) 
 
where U(x) is the potential energy associated to configurations xi and xj of the system at 
temperatures Ti and Tj, respectively. 
At the higher temperature replicas, transitions over moderately high free energy 
barriers are facilitated along all of the degrees of freedom of the system. At the same time, 
the canonical distribution is guaranteed at the lowest temperature T1. The latter represents 
the reference replica, and is set to the real temperature of interest for the simulation. 
Therefore, the procedure has the clear advantage of including states, in the configurational 
space sampled at T1, that would not be easily accessible to a traditional simulation 
performed at that temperature value.  
According to equation 21, the acceptance probability for an exchange is strictly 
dependent on the overlap between the energy distributions of neighboring replicas. The 
acceptance ratio between adjacent replicas, expressed as the ratio between attempted and 
successful exchanges, is here an important parameter. By monitoring the acceptance ratio, 
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we assess that an adequate number of replicas have been appropriately distributed in the 
considered temperature range, as to guarantee sufficient overlap that allows for the desired 
exchanges. It is worth mentioning that this aspect is also related to the efficiency of the 
method. In the ideal situation, one would set the PT framework to achieve a constant 
acceptance ratio between any two neighboring replicas in the considered temperature 
range. This would ensure an optimal round trip time across temperatures, that is the time 
required for a cold replica to move to the highest temperature and come back, and is a 
measure of the efficiency of the setup.  
Energy fluctuations for a molecular system increase with temperature. As such, going 
from T1 to TN, the difference in temperature between adjacent replicas can be gradually 
increased in order to maintain the same extent of overlap, and thus a similar acceptance 
ratio. Traditionally, a geometric progression of temperatures was suggested:34  
 𝑇w = 𝑇w )')| |yy (23) 
  
where Ti is the temperature value for each of the N replicas i, comprised between the 
temperature of the canonical replica, Tmin, and the one of the replica at the highest 
temperature Tmax. 
It is worth noticing that the requirement of overlap between the potential energy 
distribution is also causing the major drawback when dealing with PT. That is, in order to 
cover a certain temperature range, a significant amount of replicas is typically required. 
This, in turn, tends to translate to high computational costs to carry out efficient PT 
simulations. As discussed below, this practical issue can be attenuated by taking advantage 
of the well-tempered ensemble.35  
 
2.2.1.4 The well-tempered ensemble 
As already mentioned, with MetaD we guide sampling along specific CVs. These are 
usually functions based on geometric criteria, such as distances, angles or the RMSD. 
However, we can also bias the potential energy of the system. If this is carried out through 
the well-tempered declination of MetaD, then the simulation is taking place in what is 
called the well-tempered ensemble (WTE).35 The resulting potential energy becomes: 
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𝑈(𝑥) = 𝑈(𝑥) − 1 − T  𝑈(𝑥) − ¡¢£d[(Y)f56) ¤ (24) 
 
where g is the bias factor applied, and N(U(x)) is the number of states with potential 
energy U(x). It has been shown that this procedure has the effect of enhancing the 
fluctuations of the potential energy, while preserving the same average potential energy as 
in the unbiased ensemble. 
Since its first formulation, the potential of this approach has been highlighted in its 
combination with PT. By simulating in the WTE at each replica of a certain PT scheme, 
the energy fluctuations at each temperature are significantly increased, to an extent 
determined by the bias factor applied.36 As a consequence, the same continuous desired 
overlap can be achieved while placing the replicas at a farther distance between each other. 
Covering a certain temperature range requires, in turn, a more contained number of 
replicas. The overall computational effort required is thus considerably reduced and the 
efficiency of the method improved. 
 
2.2.1.5 Scaled Molecular Dynamics 
Another non-CV-based technique is scaled MD.19,20 When applying this method, the 
potential energy surface (PES) of the system is scaled by multiplying it for a factor l 
comprised between 0 and 1. When l equals 1, then the PES corresponds to that obtained 
from a plain MD. As we go to lower values of lambda, approaching the 0 value, the energy 
profile is increasingly smoothed. Figure 2 gives a pictorial representation of the effect of l 
on the PES. As a result, as easily understandable from the picture, the energy barriers 
between different states are lowered and thus transitions between them are facilitated. This 
behavior is equivalent to sampling at high temperatures. However, contrary to scaled MD, 
this would require shorter time steps, inevitably reducing the efficiency of the 
simulations.19  
The method was initially proposed by Tsujishita et al.,20 and was subsequently 
reconsidered and exploited by Sinko and coworkers.19 Under scaled MD conditions, the 
canonical probability distribution for a given state of the system is modified to: 
 𝑝∗(𝑥) = 𝑒%p(Y) 56⁄ ) (25) 
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Figure 2. Effects of the scaling factor on the potential energy surface of the system. As more aggressive l 
values are applied (that is, smaller), the potential energy profile is increasingly smoothed. 
 
where V(x) is the potential energy along a generic reaction coordinate x, kB is the 
Boltzmann constant and T is the temperature. 
In the implementation from Sinko et al., a population-based reweighting scheme was 
proposed to reconstruct the canonical distribution of populations: 
 𝑝(𝑥) = 𝑝∗(𝑥)T ⁄  (26) 
 
It is worth noticing that it is possible to envisage other reweighting schemes, including 
for instance an energetic term. However, it was shown that the population-based strategy is 
more accurate, as energy terms are subjected to larger energy fluctuations that introduce 
larger errors.19  
 
2.2.2 Recovering kinetics 
 
2.2.2.1 Markov State Models 
In computational biology, MSM construction is typically based on plain MD trajectory 
data.17,37,38 There is bit of a shift of perspective compared to the traditional interpretation of 
computer simulations, as with MSM we analyze MD trajectories through a purely 
statistical approach. The clear advantage for computational biologists is the possibility of 
aggregating multiple, shorter plain MD simulations to achieve a description of longer 
timescale kinetics. Nevertheless, adequate sampling obtained via plain MD is necessary to 
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construct the model. Specifically, all of the states accessible to the system need to be 
visited with statistical significance. To this end, the model itself, as we construct it, is able 
to give guidance about those regions of the phase space for which more sampling is 
required. Notwithstanding this capability, considerable computational resources are 
typically required to gather sufficient data to construct a reliable MSM.  
The approach represents a systematic way of decomposing the configurational space 
of the molecular system into a set of microstates. By counting the transitions in the 
microstate space according to what observed in the plain MD trajectories, one is able to 
calculate a transition matrix. Such matrix contains the transition probabilities between the 
microstates. Besides transitions probabilities, several useful properties of the system can be 
calculated. In particular, the slowest relaxation timescales, long-living states, that is 
metastable states, and also pathways and rates involved in the transition from one 
microstate to another, can be determined. 
In the following sections, we provide some insights into the major concepts behind the 
construction of a MSM, namely state decomposition, count of the transitions and coarse 
graining. 
 
2.2.2.1.1 State decomposition 
The core concept behind the construction of a MSM is state decomposition.37 
Generally speaking, a MSM is essentially a transition probability matrix in which the 
probabilities of going from one state to a different one are stored. In the context of MSMs, 
the term microstate is preferred. A critical step is thus the definition of the microstates in 
which a certain molecular system can be found. In practice, this corresponds to 
decomposing a broad configurational space, characterized by a plethora of possible 
configurations of the system, into a finite, valid set of microstates that provide a suitable 
representation of the initial configurational space. This procedure is named state 
decomposition. In order to achieve such discrete subdivision, clustering is the natural 
choice, with the obtained different clusters representing different microstates accessible to 
the system. If we were able to compute the average transition time between all of the 
configurations sampled in a MD simulation, such average transition time would be the 
obvious variable on which carrying out clustering. Then, on a hypothetic journey in the 
microstate space, at each step the system would loose its memory about previously visited 
microstates. Thus, reaching the next microstate would be simply a deterministic function 
of the microstate on which the system currently lies. This is called the Markov property, 
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and is an essential characteristic that needs to be fulfilled by a MSM. This is true if no 
significant internal energy barriers exist within a microstate, while barriers are found when 
we are at abandoning it. In other words, for the Markov property to hold, transitions 
between members of the same state need to be faster than transitions between different 
microstates. However, determining average transition times between pairs of 
configurations is currently not attainable. Thus, the just introduced framework would 
break. Nevertheless, we can think about a kinetically relevant clustering procedure, 
achieved through geometric criteria. Translated in more practical terms, this means 
grouping together configurations according to geometric similarity. If the result is not too 
spread, that is configurations clustered together are sufficiently similar, it becomes 
reasonable thinking that transitions between them will be fast. This, in turn, is connected to 
clustering algorithm intrinsic properties and on the subdivision of the phase space. It is not 
in the intent of the current discussion to go into details, but we mention that, as for the 
latter point, one would be tempted by a finer subdivision of the phase space as a mean to 
increase similarity within clusters. However, it needs to be kept in mind that adequate 
statistics for each microstate is also required, and this is typically inversely proportional to 
the number of clusters.  
From this illustration, the arising elements are a clustering algorithm and an 
appropriate distance metric on which applying it. By using the latter terminology, we 
intend variables that are able to capture the relevant dynamics of interest, distinguishing 
different configurations and identifying similar ones relatively to the process under study. 
In other words, variables that allow us effectively estimating geometric, and thus possibly 
kinetic, similarity between two structures. To give some examples, we might want to use 
dihedral angles to describe a small molecule possessing many degrees of freedom, while 
we might prefer distances between a-carbons to deal with a major conformational change 
in a protein. As in many cases, there is no general rule and a distance metric that fits all of 
the possible scenarios, thus the choice is left to the user depending on the specific scientific 
problem. In a nutshell, when constructing a MSM, as a first step we map all of the sampled 
configurations on the chosen distance metric.  
For what concerns clustering, a plethora of algorithms have been reported in the 
literature over the years. Among these, K-medoids, K-means, K-centers, regular spatial 
and regular temporal have been reviewed for application in the context of MSMs.39 By 
examining published papers on MSMs,40–42 we deduced that a popular choice in the MSM 
community is the K-means clustering algorithm.43,44 In K-means, data points belonging to 
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the same cluster present minimal pairwise distances. This is achieved by minimizing the 
following function: 
 𝐽 = ∑ ∑ 𝑑d𝑥w − 𝑐fgwjT,Y|∈«5jT  (27) 
 
where k is the number of clusters, n is the amount of data points contained in the cluster, 
and d(xi-cj)2 is a function estimating the distance, in units of the distance metric selected, 
between the data point xi and the cluster center cj. In subsequent iterations, the cluster 
centers are recalculated and data points reassigned to the closest centroid. The iteration 
keeps going until cluster centers do not change anymore. 
One reason of K-means popularity, in the first place, is its tendency to generate 
microstates including a more similar number of configurations. Put differently, the 
algorithm creates more clusters in more sampled regions. On the one hand, the clear 
advantage is that this feature helps guaranteeing more reliable estimates of transition 
probabilities, since, as previously introduced, satisfactory statistics is required for each 
microstate in order to build a meaningful MSM. On the other hand, there are drawbacks 
when using K-means. First of all, the described behavior might exacerbate resulting in an 
over-division of some regions and under-division of others. Moreover, when applying K-
means, the amount of clusters has to be specified by the user, thus requiring some sort of 
iteration in order to select an appropriate number. Finally, a cluster center is characterized 
by the average of the variable values from the configurations belonging to that cluster. 
Thus, in molecular systems, they usually do not correspond to physically meaningful 
states. Nevertheless, other strategies can be employed to easily identify representative 
structures for the generated clusters.  
As a final remark, it is important to mention the possibility of reducing the number of 
dimensions before performing clustering. The most widespread technique for this purpose 
in computational biology is undoubtedly principal component analysis (PCA).45,46 In PCA, 
a covariance matrix is calculated between chosen variables in order to identify those 
vectors on which the highest variance of the data can be projected. For instance, if we use 
Cartesian coordinates from a MD trajectory as input variables, the method prioritizes 
vectors along which the largest motion has been observed during the simulation. Another 
possibility, that is undoubtedly gaining increasing attention, is time-lagged independent 
component analysis (TICA).42,47,48 The underlying concepts are similar to those of a PCA, 
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however here the focus is on the timescales. Instead of weighting vectors according to the 
variance, we prioritize those vectors that incorporate the slowest motions. To give an 
example, let us consider the MD simulation of a globular protein comprising structured 
domains and loops. Now, let us assume that no significant structural rearrangement took 
place, while the most significant fluctuations are observed in non-interesting loop regions. 
If we performed PCA on all of the a-carbon coordinates, the first components would likely 
comprise loop motions as they were the widest in terms of displacement. Conversely, if we 
performed a TICA, we would not likely see loop motions as the relevant component, 
because they are typically fast motions and thus less relevant in term of timescales. In the 
first place, our choice of variables could result in an extremely large number of dimension, 
thus we might just want to contain it. Differently, we could consider performing TICA in a 
pure kinetic perspective. Since its purpose is focusing on the slowest motions, our data 
would somehow result cleaned of the least relevant information in this sense. However, it 
is worth noticing that interpreting outcomes from dimension reduction techniques is not 
straightforward, and moving our distance metric towards a component space might result 
in a less intuitive microstate definition. 
 
2.2.2.1.2 Counting the transitions 
Through state decomposition we discretize a configurational space, thus allowing for a 
computationally manageable description of a molecular system’s dynamics. Essentially, 
we identify clusters that correspond to possible states, referred to as microstates in this 
framework. In a MD trajectory, each frame corresponds to a specific configuration of the 
system, which can be assigned to a certain microstate among those identified. By carrying 
out this assignment, we can convert our conventional trajectory, that is a series of 
structures over time, into a discrete trajectory, that is a series of microstates visited over 
time. In a more general view, we are doing nothing more than assigning data points to 
previously defined clusters. With these discrete trajectories in our hands,37 we can follow 
the journeys taken by a molecular system around the microstate space. In particular, we 
can make jumps of fixed size while accompanying the system on these journeys. As each 
of these jumps substantially corresponds to a transition from a certain microstate to a 
different one, we can record the number of transitions observed between each pair of 
microstates and store them in a matrix. The result is a count matrix C. Thus, for each point 
ij of this matrix, Cij is the number of transitions between microstates i and j. Ideally, in the 
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limit of ergodic sampling, each count Cij could be converted in the corresponding transition 
probability Tij by simply maximizing the likelihood of the function: 
 𝑇w(𝜏) = ­|∑ ­|®®   (28) 
 
where the summation runs over all of the possible k transitions observed from state i, and t 
is the jump size. With a transition probability matrix in our hands, we would be able to 
determine the slowest motions implied in the dynamics under study, metastable states 
populated by our system, and the most likely pathways leading from a certain microstate to 
another one. However, several issues arise in real life, such as finite sampling for the 
microstates, and imperfections in state decomposition, the so-called discretization error. As 
a result, obtaining transition probability matrices translates into more complicated routines 
that we will not go through in the current illustration.  
Focusing back on the transition counts, a criterion for jumping over the discrete 
trajectories needs to be considered. As already mentioned, the advancement has a fixed 
size t, so we could just keep moving forward for n steps until we reach the end of the 
considered discrete trajectory. In this more intuitive scheme, shown in Figure 3A, we are 
gathering independent counts. This would work in the limit of infinite sampling, or at least 
of sufficient sampling for the slowest relaxation time. Again, this is not the case in real life, 
and it would cause imprecise estimation of transition probability matrices. The reason is 
that a large fraction of the data is neglected as we jump over it, thus less statistics is 
obtained for each point of the count matrix.  
 
 
Figure 3. Schematic representation of the two methods for counting transitions over discrete trajectories. The 
series of numbers represents a sample sequence of microstates, that is a sample, short discrete trajectory. 
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Thus, in the vast majority of cases, it is common practice to exploit a sliding window 
scheme, as depicted in Figure 3B. Contrary to the previous strategy, in this case we 
consider all of the available information. However, it has been noted that this has the effect 
of underestimating the model uncertainty, so it needs to be taken into account when 
assessing it.37  
Besides state decomposition, a second critical element when constructing a MSM is 
the size of the jumps. This is called the lag time of the model, and, as already shown, is 
expressed as t. Roughly speaking, it coincides with a multiple of the input trajectory time 
step, intending the frequency with which frames have been saved and not the integration 
time step of the simulation. The lag time somehow defines the highest resolution of the 
model. In other words, we cannot expect to be able to extract information about events 
occurring at timescales smaller than t. The lag time corresponds to the Markov time, 
which is the smallest size used to gather the transition counts that guarantees Markovian 
behavior. The approach that is typically followed to determine such lag time relies on 
monitoring how relaxation time scales, usually referred to as implied time scales, depend 
on it. As Markovian dynamics implies constancy of implied time scales on t, we can assess 
at which value of t the time scales reach a plateau, and then use such value to build the 
model. An example is given in Figure 4. 
 
 
Figure 4. A typical implied timescale (ITS) plot. Relaxation timescales are calculated at increasing lag times. 
The Markov time is the lag time value at which the curves reach a plateau, as they become independent from 
t. Adapted with permission from Ref.39 Copyright 2017 American Chemical Society. 
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Given a transition probability matrix, through diagonalization we obtain the 
corresponding eigenvectors and eigenvalues. While the former describe specific transitions 
of the system, from the latter we can determine the time scales at which these motions 
occur. Such relaxation time scales are computed according to the function: 
 𝑡w = − l¡¢|  (29) 
 
where li is an eigenvalue of the matrix underlying the MSM. According to this framework, 
calculating the implied time scales requires having at disposal a transition probability 
matrix, and this in turn means that a MSM has been constructed. Therefore, since we 
compute the time scales at increasing t values in order to spot the Markov time, this 
translates essentially to constructing a series of MSMs at different lag times. Finally, once 
the eigenvalue spectrum becomes stable and independent from t, we use that t to build the 
model.  
In conclusion of this general illustration, it is worth noting that another relevant aspect 
when constructing a model is its validation. For what concerns MSMs, a lot of effort is 
currently focused in this direction. Nevertheless, approaches exist already, and have been 
widely used, to test the robustness and thus a significant part of the validation process.39 
Among these, the Chapman-Kolmogorov test is undoubtedly the most popular.38 For a 
certain transition probability matrix calculated applying a certain lag time t, we evaluate 
the probability of remaining within a certain microstate A at later times kt, where k defines 
multiple integers of t. The same procedure is performed on the original data set, that is the 
discrete trajectories, and the results are compared. This is expressed by the following 
function: 
 𝑝¯°(𝐴, 𝐴; 𝑘𝜏) = 𝑝¯P¯(𝐴, 𝐴; 𝑘𝜏)  (30) 
 
and, in practice, we assess how well the equation holds. This should be performed for the 
achievable kt values, according to the original dataset. With this test, we estimate the self-
consistency of the constructed model, as we evaluate how well it is able to reproduce the 
information that has been used to parameterize it. However, the equality is not expected to 
hold exactly, because of statistical uncertainties due to finite sampling for the estimation of 
the transition probability matrix.38 Thus, uncertainties are calculated for the probabilities 
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from the discrete trajectories, that is the initial MD trajectory data. Then, the result is 
positive if equation 30 holds within the uncertainties for the MD data. Typically, the 
procedure is repeated constructing several MSMs at different lag times, and showing that, 
at that the chosen t, a satisfactory result for the test is achieved.  
 
2.2.2.1.3 Coarse graining 
While precious information about both thermodynamic and kinetic properties of a 
molecular system is engraved in a MSM, connecting back with the biology is not an easy 
task. An extremely wide configurational space has been discretized into a finite number of 
microstates. However, since the number of microstates is still very large, interpreting 
transition networks is challenging and typically not intuitive. Therefore, one can coalesce 
microstates into a reduced number of macrostates. This procedure is referred to as coarse 
graining the model. While, after contracting the complex picture into a set of few states, 
the possibility of a reliable, quantitative prediction is likely to be lost, however important 
indications can still be provided to direct new investigations. By coarse graining, we 
identify those transitions that correspond to the slowest timescales. These essentially 
underlie the higher barriers between the relevant metastable states of the molecular system.  
Several techniques have been developed to carry out the coarse graining step. Herein, 
we mention Perron Cluster Cluster Analysis (PCCA)49,50 and the more robust version 
PCCA+.51,52 We remand the reader to the literature for technical insights about these 
methods. Herein, we give some general details about the logic behind. To facilitate the 
illustration, we follow Figure 5. As already said, for a given transition probability matrix, 
that is, for a given MSM, we can calculate eigenvectors and eigenvalues. A sample 
eigenvalue spectrum is shown in Figure 5C. While, as explained, the eigenvalues can be 
converted into timescales, the corresponding eigenvectors represent the transition that is 
occurring at that timescale. In reality, the components of the first eigenvector, 
corresponding to the first, thus largest, eigenvalue, are proportional to the equilibrium 
population of the states and is usually neglected. For the other eigenvectors the conversion 
to timescales is meaningful. In particular, from the second eigenvalue we determine the 
slowest timescale. The corresponding eigenvector describes the transition between the 
metastable states separated by the highest energy barrier. This, in Figure 5A and B, is 
represented by the transition between states B and C. According to the same logic, the third 
eigenvector expresses transitions over the second highest barrier, separating metastable 
states A and B, and so on. 
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Figure 5. Coarse graining into relevant metastable states. A) A potential energy function comprising four 
metastable states, separated by three energy barriers. B) The four dominant eigenvectors calculated from a 
hypothetical transition probability matrix. C) Eigenvalue spectrum (the first fifteen are shown) and the 
corresponding relaxation time scales. Adapted with permission from Ref.39 Copyright 2017 American 
Chemical Society. 
 
As shown in the example, given three energy barriers, we would observe three slower 
timescales. This would be highlighted by the presence of a gap between the fourth and fifth 
values in the eigenvalue spectrum. This general framework is exploited by PCCA and 
several other methods to perform coarse graining. In this specific example, where three 
clear barriers are present, microstates would be grouped into four metastable states. 
However, in most cases the separation of timescales is not as clear as in the shown 
example. In such circumstances, the number of microstates can be interpreted as an 
adjustable parameter that a user can eventually comment according to the corresponding 
outcoming picture.37  
 
2.2.2.2 Bin-based kinetic model 
When it comes to sampling wide and complex configurational spaces, enhanced 
sampling methods are typically preferred over plain MD. Besides being hazardous, as 
access to all of the relevant regions is not guaranteed a priori, plain MD by definition calls 
for more onerous computational resources. However, when exploiting enhanced sampling 
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techniques, we loose completely the information about the time, and we can only discuss 
in terms of energetics. Given that a reconstructed FES is sufficiently accurate, and that the 
choice of CVs allows for an unambiguous description of the configurational space, we 
would be able to identify univocal metastable states and quantify the height of the barriers 
separating them. With this information, one should be able, at least in theory and through 
approximations for the pre-exponential factor, to compute kinetic rates. However, this 
might not be the case and other strategies need to be envisaged to extract kinetic 
information from biased sampling. A possible way is the construction of a kinetic model 
based on the free energy. Herein, we provide a general description of relevant theoretical 
features underlying a kinetic model based on a binning procedure of the FES.26  
 
2.2.2.2.1 Kinetic Monte Carlo 
As for a certain molecular system we can expect different states, a rate constant kij can 
be considered that describes, per time unit, the probability of escaping from a certain state i 
in favor of a certain state j. Transitions between different, relevant states are infrequent if 
compared to local fluctuations within a specific state. In other words, once it enters state i, 
the system is going to spend more time fluctuating locally before being able to leave it and 
reach another state j. Thus, transition probabilities from i to j are independent from 
previously visited sates. We say that the system is memoryless in this case, and the 
corresponding walk in the state space is called Markovian. In this picture, leaving i is a 
first-order process and: 
 𝑝w(𝑡) = 𝑘w𝑒%5|Z (31) 
 
represents the probability distribution function of the first escape time towards state j. 
For each state i of the system, a set of possible states j is accessible, and to each one of 
these different pathways is associated a specific kinetic rate kij. If we knew the values of 
each kij, we would be able to correctly describe the dynamics in the state space by means of 
a stochastic algorithm. One engine that is available to propagate the system along this 
Markov walk is Kinetic Monte Carlo (KMC).53  
We describe herein the simplest implementation for illustrative purposes. From the 
exponential first-escape time distribution, we can draw an exponentially distributed 
random number: 
 36 
𝑡²³R´ = − T5 ln 𝑟 (32) 
 
where k is a rate constant associated to a certain path and r is random number comprised 
between 0 and 1. Basing on this, we can produce a trajectory by generating, at each step, 
tdraw for each kij associated to the accessible pathways. The lowest time tjmin towards state j 
is going to be chosen and the overall clock of the simulation updated by adding tjmin. The 
procedure is then repeated from the state j. 
 
2.2.2.2.2 Bin-based procedure 
With enhanced sampling methods, the bias has the effect of pushing the system 
towards relevant regions of the CV space. As such, transitions take place at simulation 
times that do not reflect the real dynamics. Therefore, transition probabilities calculated 
from the transitions observed in the biased trajectories cannot be used to determine real 
rates. However, since by means of enhanced sampling techniques we can reconstruct a 
FES, to which kinetic properties are intimately related, it is possible to derive free energy 
based models describing the kinetics of the system. Herein, we discuss a kinetic model 
based on a binning procedure of the FES.26  
For a given FES described by N CVs, we can define small volumes in this CV space 
representing a certain state of the system, characterized by a specific value of the free 
energy. To this end, a binning procedure can be applied. The values spanned by each CV 
can be discretized in equal increments, each one of which defines one of the N sides 
delineating a small volume. When executing this procedure, both large and small bin sizes 
are not advisable. Since transition probabilities between bins are evaluated in order to 
construct the model, collecting sufficient statistics for each bin becomes more challenging 
as we reduce the size, and thus increase the number, of bins. As for large size, and thus low 
number, of bins, this brings to a poor description of the underlying FES, loosing resolution 
of the minima identified. 
In this bin-based kinetic model, the transitions between pair of bins a and b are 
regulated by the following definition of rate: 
 𝑘¶· = 𝑘¶·k 𝑒%d¸¹% º¸f g56)⁄   (33) 
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where Fa and Fb are free energy associated to bins a and b, T is the temperature of 
interest, and k0 is the rate corresponding to simple diffusion on a flat free energy surface, 
considering k0 equal for transitions from a to b and from b to a. In this formulation, the 
probability of visiting bin a is proportional to the negative exponential of Fa, thus visiting 
lower energy states is more likely. The rates k0 depend on the diffusion properties of the 
system in the reaction coordinate, that is CV, space and on the sides of the bins. In the 
simplest, one dimensional example: 
 𝑘(w)(w±T)k = °²¼X (34) 
 
where k0 between neighboring bins i and i±1 is calculated from the diffusion 
coefficient D and the side ds of the bin in the single reaction coordinate space. In d 
dimensions, D becomes a matrix that stores the different values of the diffusion coefficient 
for dynamics in all of the possible direction of the d dimensional space. As a result, for 
each possible direction in bin space, k0 is estimated from the respective bin sizes and 
elements of the diffusion matrix.  
In order to determine the diffusion matrix, one performs several plain MD runs started 
at different points of the CV space. If relevant metastable states are known, the accuracy of 
the procedure can be improved by starting the simulations from the regions they belong to. 
As a good practice, representative structures can be extracted from the minima identified in 
the FES. The trajectories are then projected in the bin space by applying a certain lag time 
t. Basing on the associated CV value, each frame of the trajectory is assigned to a specific 
bin. Thus, a trajectory is converted from a series of structures into a series of bins. We then 
make jumps of integer size t, and record the transitions observed accordingly. This 
information becomes the ground on which determining the diffusion matrix. Starting from 
the bins visited in the MD runs and using the same t, several KMC trajectories are started 
to visit the bin space with a k0 based on an initial guess value for D. Through the KMC 
runs, the transition probabilities between pair of bins at lag time t are computed as: 
 𝑝°(𝛾|𝛽) = d(l)|·(k)f(·)  (35) 
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where n(b) is the number of times state b was visited, and, considering to be in that state at 
time 0, n(g(Dt)|b(0)) counts the number of transitions to state g at time t during the KMC 
simulation. Finally, taking advantage of these transition probabilities, we can express the 
likelihood of observing the same sequence of bins obtained from the MD trajectories as: 
 𝐿(𝐷) = 𝑙𝑜𝑔∏ 𝑝°d𝛼(𝑡 + 𝜏)|𝛼(𝑡)fZ  (36) 
 
By maximizing equation 36 as a function of D, we eventually determine the diffusion 
matrix for our kinetic model. Another aspect to consider is the dependence of D on the lag 
time. As a typical behavior, as t increases, D increases consequently until it converges to 
defined values. At that point, the dynamics in the bin space is approximately Markovian. 
This means that transition between states are memoryless, they only depend on the current 
states and not on previously visited ones. Under such circumstances, the constructed 
kinetic model returns a good approximation of the dynamics of the system. The t from 
which the Markovian behavior is observed is called Markov time. This corresponds to the 
highest resolution of the kinetic model. Thus, transitions occurring at timescales lower than 
the Markov time cannot be reproduced. In conclusion, one maximizes the likelihood as a 
function of D for different values of t, until the elements of the diffusion matrix converge 
to stable values.  
Once D is determined, we have all of the ingredients composing the kinetic model. We 
can thus perform KMC trajectories in the bin space. These are started from each bin, and 
those on which most of the trajectories end are used to define the main kinetic basins. 
Finally, starting KMC runs from each kinetic basin, one can record the average time 
required to visit each one of the other basins and calculate the corresponding rates. 
 
2.2.2.3 Relative residence time 
The residence time of a certain ligand towards a specific biomolecular target estimates 
for how long that ligand is able to occupy the binding site of that target. Such quantity, 
determined as the inverse of the unbinding rate constant, has recently gained much interest 
in drug discovery.5,6 A longer residence time for a certain drug translates to extended 
modulation of the activity of the target biomolecule. As such, the resulting 
pharmacological effect is prolonged. In the vast majority of cases, this is a desired 
scenario. Therefore, being able to assess kinetic profiles for drug-like molecules during the 
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optimization phase of a drug discovery campaign would be extremely desired. In 
particular, the possibility of predicting efficiently such properties for a series of 
compounds by means of computational methods would provide a significant improvement 
to the optimization pipeline. Although significant efforts are currently being focused on 
determination of on- and off-rates through computer simulation, assessing absolute values 
of these kinetic parameters still represents a major challenge. Considerable efforts are 
required in terms of both computational resources and user intervention for system-
dependent setup. Thus, such framework does not provide appealing strategies that could be 
applied to several protein-ligand systems in a routinely manner. 
In a typical optimization scenario, several analogues of a hit compound are considered 
in order to identify chemical substituents that result in an increased activity. Similarly, 
being able to prioritize chemicals with improved kinetic profiles would be of striking 
support. Recently, a methodology based on scaled MD19,20 has been introduced that allows 
ranking a series of similar ligands according to their computational unbinding times.21 
Despites these are not the real residence times, they can still be employed in a relative 
manner to prioritize promising ligands within a series of congeneric compounds. Thus, 
rather than aiming at an accurate determination of the absolute values of unbinding rates, 
the goal is a ranking of the ligands, so as to identify those characterized by a prolonged 
occupation of the binding site. Relying on scaled MD, multiple unbinding events for each 
ligand can be sampled in reasonable times, making the procedure more suitable and 
appealing for real life applications. In particular, given a series of analogue compounds, 
several unbinding simulations can be carried out for each ligand so as to determine average 
computational unbinding times. After a rescaling procedure considering the l used in the 
scaled MD simulations, the correlation with experimental off-rates can be evaluated by 
fitting to a simple linear function.  
According to Eyring’s equation (eq. 6) and to the subsequent developments leading to 
the general formulation in which the transmission coefficient k was introduced (eq. 11), we 
can express the unbinding rate constant for a ligand from the binding site of a specific 
molecular target as:  
 𝑘ÅÆÆ = 𝜅 56)G 𝑒%∆IÇÈÈ‡ ()⁄  (37) 
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where ∆𝐺ÅÆÆ‡  is the free energy difference between the ligand-target complex and the 
transition state leading to the unbound state. By incorporating all of the non-exponential 
contributions in a general pre-exponential factor A, similarly to Arrhenius’ equation, we 
can simplify the notation of equation 37 to: 
 𝑘ÅÆÆ = 𝐴𝑒%∆IÇÈÈ‡ ()⁄  (38) 
 
For two ligands binding to a certain biomolecular target under similar conditions, we can 
assume a similar A. Therefore, we can express the ratio the ratio between their koff as:  
 
5ÇÈÈ,5ÇÈÈ,X = :xy∆qÇÈÈ,‡ ÉÊi:Xxy∆qÇÈÈ,X‡ ÉÊi ≈ :xy∆qÇÈÈ,‡ ÉÊi:xy∆qÇÈÈ,X‡ ÉÊi = xy∆qÇÈÈ,‡ ÉÊixy∆qÇÈÈ,X‡ ÉÊi = 𝑒%∆∆IÇÈÈ,,X‡ ()⁄  (39) 
 
According to the previously introduced equation 7, we can make equation 38 explicit in 
terms of enthalpic and entropic contributions: 
 𝑘ÅÆÆ = 𝐴𝑒%∆IÇÈÈ‡ ()⁄ = 𝐴𝑒%∆OÇÈÈ‡ %)∆PÇÈÈ‡  ()⁄  (40) 
 
Therefore, by applying the scaled MD l factor to equation 38 and considering the explicit 
formulation introduced in the above expression, we can write:  
 𝑘ÅÆÆ, = 𝐴𝑒%∆OÇÈÈ‡ %)∆PÇÈÈ‡ () ()i  (41) 
 
where ∆𝑆ÅÆÆ‡ (𝜆) indicates the unknown effect of l on the entropic term. Assuming equal 
entropic contributions for the two considered ligands, since we manage analogues from the 
same scaffold that are unbinding from the same protein under the same conditions, we can 
cancel out the entropic term contained in the ratio introduced by equation 39. Under this 
assumption, and considering the form of equation 39, l can be collected and the equation 
expressed as: 
 5ÇÈÈ,z,5ÇÈÈ,z,X = 𝑒%∆∆IÇÈÈ,,X‡ ()⁄  = 𝑒%∆∆IÇÈÈ,,X‡ ()⁄ z = 5ÇÈÈ,5ÇÈÈ,X (42) 
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Being the residence time tr the inverse of the off-rate, the above equivalence can be 
rewritten as: 
 ZÌ,z,XZÌ,z, = 5ÇÈÈ,5ÇÈÈ,X (43) 
 
This relationship between unscaled and scaled parameters can be used to assess the 
correlation between real, experimental values and those computed at a certain l. In this 
way, the ability of the method to correctly rank ligands in terms of the unbinding kinetics 
profile, as predicted by means of scaled MD simulations, can be evaluated.  
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3. APPLICATIONS 
 
3.1 TEST CASE 1: NTAIL 
 
3.1.1 Introduction 
 
In the last decade, it has become clear that a significant proportion of eukaryotic 
proteins are unstructured under physiological conditions.54,55 The lack of a stable 
secondary and tertiary structure is the peculiar feature of this class, hence the term 
Intrinsically Disordered Proteins (IDPs). This intrinsic disorder may involve the overall 
amino acid sequence or just be limited to specific domains. Notably, it is responsible for 
the highly dynamic nature of these proteins. Indeed, rather than possessing a well-defined, 
most probable state at equilibrium, IDPs typically exist as a dynamic conformational 
ensemble of states, among which they can easily interconvert. This feature accounts for the 
peculiar ability of IDPs to interact with multiple targets and thus to take on many 
physiological roles related to, for example, signaling or regulation.56,57 Likewise, 
dysfunctions of these proteins can lead to several pathological conditions, such as 
neurodegenerative disorders and cancer.58,59 To gain a comprehensive picture of their 
functionality and implication in diseases, it is thus essential to produce a detailed 
characterization of the equilibrium properties of free IDPs in solution, in terms of both 
thermodynamics and kinetics.  
Exploration of this part of the proteome is still in its infancy. Effective experimental 
tools for studying IDPs include NMR spectroscopy,60 small angle X-ray scattering 
(SAXS),61 and fluorescence Förster resonance energy transfer (FRET),62 which are well- 
suited to dealing with the structural dynamics of proteins. However, characterizing the 
equilibrium properties of IDPs remains challenging due to their highly dynamic nature, as 
well as the heterogeneity of the above techniques in terms of space and time resolution. 
From a structural standpoint, NMR spectroscopy has been particularly successful in 
characterizing the ensemble of conformations that collectively describe these peptides. A 
two-step procedure called “sample and select” (SAS) is typically the most common 
process for identifying a representative ensemble of structures sampled at equilibrium. 
First, a pool of configurations is generated, usually by exploiting conformer libraries. 
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Then, through an iterative process, the ensemble is filtered by satisfying the best agreement 
between experimental and back-calculated NMR observables, such as scalar couplings (J), 
chemical shifts (CSs), and residual dipolar couplings (RDCs). Notwithstanding the power 
and elegance of this approach, SAS does not provide any kinetic information on the 
implied timescales regulating the interconversion between conformations. But this 
information is instrumental to understand the folding of IDPs and the recognition 
mechanisms with molecular partners. The only source of dynamic and time-resolved 
information by NMR is the study of spin dynamics: a method for IDPs was recently 
proposed,63 based on multiple temperature measurements, to discriminate between motions 
on different timescales. However, even within the framework of this new family of 
experimental techniques, the nature of 15N spin relaxation only allows the identification of 
motions in the timescale of tens of nanoseconds, i.e. within times that are shorter than the 
ones governing the interconversion between different local structures present along a 
disordered chain (e.g. considering the folding of a helix occurring within the µs timescale). 
In this context, all-atom MD is emerging as a key tool,24,64–67 as it provides an 
ensemble of conformations in equilibrium conditions. Additionally, MD can describe the 
kinetics of the observed events,4 allowing a comprehensive picture of IDPs at a fully 
atomistic level. However, when applying MD to study slow processes such as folding and 
unfolding, extensive simulations (in the microsecond-to-millisecond timescale) are 
typically required, even for relatively short amino acid sequences.68 MD-based enhanced 
sampling methods are particularly promising in this regard, as they allow for an efficient 
exploration of the configurational space, while preserving the Boltzmann distribution of 
states in the given statistical ensemble.16 In these methods, the sampling is accelerated by 
either exploiting high temperature replicas, as in replica exchange (or Parallel Tempering 
MD, PT-MD), or through bias potentials or forces acting on selected degrees of freedom, 
which are known to describe the event one wishes to accelerate (reaction coordinates or 
collective variables, CVs). MetaD25 is one such CV-based methods that can ultimately be 
combined with PT-MD69 to further improve sampling effectiveness (PTMetaD).70 The 
ever-increasing number of computational studies focusing on IDPs71,72 demonstrates the 
strong need for robust techniques to simulate these systems. Such techniques range from 
force field optimization to the use of implicit solvent models. Interestingly, NMR can be 
directly combined with MD, leading to ensemble-restrained MD simulations.73 Within 
these approaches, chemical shifts are implemented as additional terms of the molecular 
mechanics force field.74 It has been shown that using replica-averaged restraints improves 
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the description of the protein dynamics around the native structure.75 Conversely, the so-
called NMR-guided MetaD incorporates experimental information in the form of a 
purposely designed CV. It has been successfully used to characterize the complex free-
energy landscape of the Aβ1-40 peptide.76  
The C-terminal domain (NTAIL) of the nucleoprotein of the Sendai virus, a member of 
the Paramyxoviridae family, is intrinsically disordered.77 Experimental studies on NTAIL 
and similar peptides from the same family have revealed a high helical propensity in the 
central region of the sequence, giving rise to differently folded states that are accessible to 
this class of domains (Figure 6).78  
 
 
Figure 6. NTAIL proposed conformational equilibrium in solution. The central region of the sequence (top, 
residues 476-492) encodes for differently folded states (bottom) that can be visited by the peptide. The three 
arginines (R482, R486, R490, in ice blue in the top sequence), through which the interaction with the 
molecular target PX is established, are highlighted as ice blue surface in the structures.  
 
Herein, we investigate the ability of state-of-the-art computational methods to tackle 
both the thermodynamic and kinetic aspects of IDPs. In particular, we first used the 
enhanced sampling method PTMetaD in the WTE (PTMetaD-WTE, for clarity hereafter in 
this chapter simply referred to as MetaD)35,36 to explore the conformational space of NTAIL 
and to characterize its free-energy landscape without any bias towards experimental 
observables. The reliability of calculations was then validated by comparing the back-
calculated CS with previously collected NMR data. Finally, a bin-based kinetic model was 
built to describe the interconversion between states populated by the peptide, and to 
 45 
calculate the corresponding rates. Although there were marginal discrepancies with 
structural observables, our approach succeeded in identifying all of the relevant 
conformational states of NTAIL, and can be useful in characterizing interconversion rates 
that are otherwise elusive to direct experimental investigation. In addition, the rather good 
agreement between theoretical and experimental NMR observables provides, to the best of 
our knowledge, the first quantitative assessment of MetaD to fully explore the FES of a 
disordered polypeptide. 
 
3.1.2 Methods 
 
3.1.2.1 Simulation setup 
The initial system for our simulations was prepared from conformation H1 of the 
peptide (sequence: NDEDVSDIERRIAMRLAERRQEDSAT, top in Figure 6), determined 
via NMR in a previous work. Termini were capped by adding the acetyl (ACE) and N-
methyl amide (NME) groups at the N- and C-terminus respectively. Solvation was 
accomplished by adding 15,622 water molecules in a cubic box having 78 Å edge size. Na+ 
counter ions were subsequently added to neutralize the system. A last generation force-
field was used to treat the peptide. In particular, the Amber ff99SB*-ILDN,79 resulting 
from the original ff99SB80 corrected with the “ILDN” side-chain torsion parameters and 
the helix-coil transition balance optimizations,81 was adopted. While other computationally 
more expensive simulative setups could be envisioned (e.g. Amber ff03w82 combined with 
TIP4P/200583 or Amber ff99SB-ILDN combined with TIP4P-D),84 Amber ff99SB*- ILDN 
was recently used in several studies together with cheap water models, and worked well for 
a large variety of proteins including IDPs.64,79,85–87 Accordingly, the TIP3P88 model was 
applied for the water molecules, and the ions were described as indicated in a recent 
reparameterization carried out by Joung and Cheatham.89  
After an initial minimization consisting of 5,000 steps of steepest descent, the system 
was equilibrated in two stages. First, we performed a 500 ps long simulation at 298 K in 
the NVT ensemble using the velocity-rescaling thermostat,90 with a 0.1 ps time constant 
for coupling. This was followed by 500 ps in the NPT ensemble using the Parrinello-
Rahman barostat,91 with a 2.0 ps time constant for coupling. Long-range electrostatics 
were treated via the particle mesh Ewald method.92 A cut-off of 12 Å was used for short-
ranged non-bonded interactions. All simulations were performed applying a 2 fs time step. 
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For the PT, the 298-400 K temperature range was covered with 8 replicas, 
geometrically distributed34 according to eq. 20, as discussed in the Theory chapter. 
Specifically, the obtained values were: 298.00, 310.80, 324.15, 338.07, 352.60, 367.73, 
383.53, 400.00 K. The system equilibrated at 298 K was heated up to 400 K in 7 
subsequent steps in order to obtain the starting configurations for each replica. All 
simulations were performed with the 4.6.7 version of the GROMACS MD engine,93 
patched with the PLUMED 2.1 software.94  
To run in the WTE, a preliminary 5 ns long PTMetaD run was carried out, using the 
potential energy as the only CV. Gaussians with a height W of 2.5 kj/mol and width σ of 
500 kj/mol were added every 250 steps. A bias factor of 50 was applied to ensure a 
sufficient overlap between the energy distribution of neighbouring replicas, and exchanges 
were attempted every 100 steps. The bias gathered in this preliminary run was then kept 
fixed during the subsequent PTMetaD production run, thus allowing simulating in the 
WTE. The overlap from standard PT is compared to the one achieved through combination 
of PT and WTE (PT-WTE) in Figure 7; to appreciate the improvement obtained, note that 
the same number of replicas was employed in the same temperature range.  
 
 
Figure 7. Energy distribution of replicas at increasing (blue to red) reference temperatures. Standard PT (left 
panel) is compared to PT-WTE (right panel) while employing the same number of replicas. No overlap 
between adjacent replicas was observed in the former case. Thus, a higher number of replicas would be 
required to cover the considered temperature range. The overlap was increased in PT-WTE, allowing the use 
of a reduced number of replicas to cover the same range. 
 
For the production phase, the alpha helical content (αcont)95 and the radius of gyration 
(Rgyr)96 were chosen, respectively defined as: 
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 𝛼ÍÎ¢Ï = ∑ 𝑛[RMSDd{𝑅w}w∈Öº, {𝑅k}f]¶   (44) 𝑅×ØÙ = 3∑ ||³|%³ÚÛÜ|X| ∑ ||   (45) 
 
The first CV generates a set of all the possible portions comprising six contiguous 
residues in the amino acid sequence of a peptide. The RMSD (root mean squared 
deviation) between each element of this set and an idealized six residues alpha helix is then 
calculated. These RMSDs are finally summed to estimate the overall alpha helical content 
of a certain conformation of the peptide under study. The second CV is based on the 
distance ri between each point comprised in an ensemble possessing center of mass rCOM. 
As points are more spread in the Cartesian space, Rgyr returns higher values, while it 
returns lower values if they are closer. Herein, the α-carbons in the peptide were 
considered. Thus, lower values of the CV correspond to more compact conformations of 
the peptide, while higher values correspond to more elongated ones. Gaussian with 
nominal height 0.4184 kj/mol and σ of 0.15 for αcont and 0.025 for Rgyr were deposited 
every 500 steps with a bias factor of 15. Exchanges between neighbouring replicas were 
attempted with the same frequency as the preliminary step, resulting in an average 
exchange probability of about 10% in the production phase. Each replica was simulated for 
about 400 ns, resulting in a total simulation time of about 3.2 µs. 
 
3.1.2.2 NMR data prediction 
As reported in the past in a work published by some of the authors of the present 
publication,97,98 experimental chemical shifts (δexp) have been extracted and tabulated from 
the original paper and put in comparison with chemical shifts predicted by means of an 
iterative use of an existing software. In this case, chemical shifts (specifically Cα, Cβ, C', 
N, HN, Hα) have been predicted (δpred) using SPARTA+,99 a software based on artificial 
neural networking, applied to single structures extracted from the trajectories of each 
simulation every 0.1 ns, with chemical shifts calculated for each of them and then 
reweighted as follows: 
 𝛿ÞÙßà = 	∑ 𝑤Y,w£wjT 𝛿ÞÙßà,w  (46) 
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where wx,i represents the weight w attributed to the single structure i according to method x, 
and δpred,i is the chemical shift predicted for the structure i. The root mean square deviation 
(RMSD) between δpred and δexp for each nucleus has been calculated over all the residues j 
(excluding the N and C termini ones) according to the formula: 
 RMSD =	 T£ 	3∑ d𝛿ÞÙßà, − 	𝛿ßãÞ,fgäjg   (47) 
 
A total number of 80055 structures have been extracted from the original trajectory, 
and four different methods have been adopted to assign weights: 
a. a clustering of the structures based on the simple linkage method, i.e. a structure has 
been added to a cluster when its distance to any element of the cluster computed on 
the protein backbone between residues 473 and 496 was less than 1 Å; a total of 4335 
clusters have been obtained, whereas only 594 clusters containing more than 3 
members have been considered for the final chemical shifts and residual dipolar 
couplings calculations and statistics; 
b. a binning of the FES obtained from MetaD simulations has been adopted that led to 
2912 Boltzmann weighted representative structures of NTAIL; 
c. a “sample and select” procedure has been used to select an ensemble of 7858 
structures that optimize the agreement between the predicted and the experimental 
observables, i.e. the set that best minimizes the following RMSD-based figure of 
merit, namely 𝑤RMSD = RMSDuα + RMSDuv + RMSDuβ where RMSDCα, 
RMSDC’, RMSDCβ, are respectively the RMSDs between experimental and 
computed values of Cα, C’ and Cβ chemical shifts, with the last one reduced in weight 
due to its relative insensitivity to secondary structure variations. The limit value of 
wRMSD that led to the ensemble was chosen to be 2.75 ppm. 
d. a sampling method based on the bin-based kinetic model, with a population attributed 
to the NTAIL microstates after numerically solving the equations that describe the 
interconversion between them. 
 
3.1.2.3 Kinetic model setup 
In our binning scheme, we first explored the possibility of exploiting the free energy 
landscape projected onto the 2 CVs used to bias our MetaD simulation. We thus divided 
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the FES obtained into different combinations of N x M grids, where N and M are the 
number of bins along αcont and Rgyr, respectively. However, even using finer grids (e.g. 70 
x 40) this approach resulted in significantly dissimilar conformations being grouped in the 
same microstate. Same αcont values can be shared by conformations in which the helicity is 
positioned in different, diametrically opposite regions along the peptide sequence (see 
sample structures belonging to a same energy minimum in Figure 10 of the following 
Results and discussion section). This observation led us to identify Δα as a promising, 
effective CV able to discriminate the location of the α-helices in the structure: 
 ∆𝛼 = d𝛼ÍÎ¢Ï,T%T − 𝛼ÍÎ¢Ï,Tå%gæf  (48) 
 
where indices 1-13 and 14-26 refer to the first and second half of NTAIL sequence 
respectively. Positive values of the variable indicate the helicity prevails in the first half of 
the peptide, while negative values in the second one. 
Thus, relying on the reweighting scheme developed in previous studies, we projected 
the FES in the two-dimensional space of the αcont and Δα CVs (Figure 13 in the Results and 
discussion section), and carried out the binning procedure introduced above. We divided 
our FES applying different combinations of N x M. The best compromise between number 
of bins (which influences microstate populations) and conformational consistency within 
the microstates was achieved applying a 40 x 8 grid along the CVs, αcont and Δα 
respectively. 
To determine D in our CV space, we carried out 4 plain MD simulations, 100 ns long 
each. The initial structures were chosen among medoids identified via the cluster analysis, 
and were selected to be as much distant as possible along the αcont CV. For each trajectory, 
we computed D at increasing values of Δt. The diagonal elements of D, named D11 and 
D22 respectively, converged at Δt = 8 ns (Figure 8A). As for the off-diagonal terms, we 
deducted from our calculations that they need to be 2 orders of magnitude lower than the 
diagonal terms. For calculation of the kinetic rates, the average value of D obtained at Δt = 
8 ns in the 4 simulations was applied. We also assessed the dependence of D on trajectory 
length at fixed Δt. One out of the 4 trajectories was extended to 200 ns, and D elements 
computed at increasing trajectory length, namely 25, 50, 100, 150 and 200 ns (Figure 8B). 
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Figure 8. A) Convergence of the diffusion matrix D. The diagonal elements D11 (blue) and D22 (red) are 
reported as a function of the time lag (Dt). Error bars represent the standard deviation obtained after 
averaging over the 4 plain MD trajectories. B) Dependence of diagonal elements D11 (blue) and D22 (red) 
on simulation time. Y axis are shown in log scale in both panels. 
 
While no clear-cut separation among the times scales could be identified in the 
eigenvalue spectrum obtained from the transition matrix computed applying the 
determined D, a noticeable slope change was at approximately the fourth or fifth 
eigenvector. Thus, a series of kinetic models were built including an increasing number of 
states, ranging from 3 to 6. In retrospect, we decided to employ the kinetic model including 
six states, since six was the minimum number required to observe the four experimentally 
derived conformations in individually distinct states. We computed the kinetic rates by 
performing 100 KMC simulations between each pair of the six identified states.  
 
3.1.2.4 Calculation of equilibrium populations 
Having a set of kinetic constants of formation and disruption of all the microstates 
identified by our kinetic model is in principle possible to compute the theoretical 
equilibrium concentration of each species by means of a set of differential equations that 
describe the rate of formation of each species present in the system. Every interconversion 
can be seen as a first order kinetics process that allows a transformation of one microstate 
into all the others and vice versa. Hence, the rate of formation/disappearance of A (as well 
as the one of the other states) can be described by the following differential equation that 
takes into account the coexistence of several interconversion processes: ²[:]²Z = 	 (−𝑘>:[𝐴] +	𝑘:>[𝐵]) +	(−	𝑘­:[𝐴] +	𝑘:­[𝐶]) + (−	𝑘°:[𝐴] +	𝑘:°[𝐷]) +(−	𝑘&:[𝐴] +	𝑘:&[𝐸]) + (−	𝑘¸:[𝐴] +	𝑘¸:[𝐹]) = 	−∑ 𝑘w:[𝐴]w + ∑ 𝑘:w[𝑖]w   (49) 
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where [A], [B], [C], [D], [E], [F] indicate the concentration of microstates, kiA (with i = B, 
C, D, E, F) are the rates of interconversion of any state i into A and kAi are the rates of 
interconversion of A into any other state i. In this way, the kinetics of the system can be 
fully described by six differential equations in the same form of equation 49, and they have 
been numerically solved with the help of the program for symbolic calculations SAGE100 
imposing the boundary condition: 
 [𝐴] + [𝐵] + [𝐶] +	 [𝐷] +	[𝐸] +	[𝐹] = constant  (50) 
 
for respecting the physical condition of the conservation of mass during the 
interconversion time, and approximating the system of differential equations putting to 
zero the kiA and kAi that correspond to interconversion times longer than 300 ns. 
 
3.1.3 Results and discussion 
 
We designed our experimental studies to achieve a thorough understanding of the 
conformational dynamics adopted by free NTAIL in solution. In previous works, plain MD 
has been applied to sample the conformational space of proteins, and average 
spectroscopic observables have been predicted in agreement with experiments, thus 
certifying the reliability of the simulations.98,101 Similar procedures have been presented in 
the context of enhanced sampling and employed to study structured proteins.97,102 
However, to the best of our knowledge, such framework has not been explored for 
structurally heterogeneous systems such as IDPs. Our study on the IDP NTAIL revealed an 
ensemble comprising a random coil (RC) in equilibrium with differently folded states, 
involving residues ranging from 476 to 492.78 In particular, conformation H1, in which 
five consecutive residues from the first half of the peptide form a small helix, has been 
reported as predominant by NMR experiments. We tackled this heterogeneous 
conformational space by exploiting MetaD. Our sampling strategy used two general 
purpose CVs, namely the radius of gyration (Rgyr)96 and the α-helical content (αcont).95 To 
improve the sampling effectiveness along the orthogonal degrees of freedom not explicitly 
included in the CVs, we used eight replicas spanning a temperature range of more than 100 
K, together with enhanced potential energy fluctuations (WTE framework, see Figure 7 in 
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the Methods section). Notably, a similar setup was recently used by Han et al. to study the 
free-energy landscape of the closely related measles virus (MeV) NTAIL.103 Our simulations 
reached a satisfactory convergence of sampling after 2.6 µs (325 ns per replica, Figure 9).  
 
 
 
Figure 9. Convergence of the MetaD simulation. A) Free energy surface as a function of the simulation time. 
B) Unsigned free energy difference between the deepest minima, namely the ones located at αcont = 1.5 and 
9.5, as a function of the simulation time. 
 
The result was a relatively flat and rough free-energy surface (FES), displaying 
multiple shallow energy minima (Figure 10). In the obtained energy landscape, the basins 
are mostly distributed along the αcont CV, indicating the presence of a plethora of 
conformations possessing different and increasing secondary α-helix content. Structural 
characterization of these minima, achieved with a k-medoids clustering algorithm,104 
revealed differently folded states represented by α-helices mostly distributed in the 
peptide’s central region. Notably, our simulation strategy reproduced all the relevant 
conformations previously identified by NMR experiments. In the free-energy landscape 
obtained, the relevant minima, mostly iso-energetic, are found at increasing amounts of 
helical content (αcont ≈ 1, 3, 6, and 9) and reasonably small values of radius of gyration, 
always lower than 14 Å. The random-coil conformations of NTAIL were characterized by 
the lowest αcont values (αcont ≈ 1 and Rgyr < 12 Å). 
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Figure 10. Free-energy surface of NTAIL obtained from the PTMetaD-WTE simulations. Contour lines are 
reported with intervals of 2 kcal/mol. Representative structures from each local minimum are also shown. 
 
Notably, in this region of the CV space, we could also identify β-hairpin motifs. This 
reflects the ability of our MetaD setup to efficiently identify conformations bearing 
structural elements that were not explicitly accounted for by the CVs used. Interestingly, 
the most extended helix identified by NMR measurements, spanning 15 residues 
(conformation H3, 478-492), was sampled at approximately αcont ≈ 9 and Rgyr ≈ 12 Å 
together with differently folded intermediates. Conformation H2, comprising 13 residues 
(476-488), was found at αcont ≈ 6 and Rgyr ≈ 12 Å, in a minimum separated from the 
previous one, and from the one including the least folded conformation H1 (αcont ≈ 3 and 
Rgyr ≈ 8 Å). Moreover, a fully folded state (αcont > 18) was observed in a region of higher 
free energy (ΔF > 6 kcal mol-1). 
The conformational ensemble reconstructed by MetaD simulations was validated by 
assessing its ability to reproduce observed NMR chemical shifts. As demonstrated in 
previous works, single structures cannot provide accurate atomic level reproductions of 
polypeptide chain experimental data. However, including dynamic information 
dramatically improves these reproductions, encoding into single experimental observables 
the heterogeneity of structures due to thermal motions. 
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Applying the same type of approach previously adopted for structured proteins, we 
calculated the expected 13C, 15N, and 1H backbone chemical shifts for each structure of the 
ensemble using the SPARTA+ program.99 For all nuclei, we evaluated the RMSD between 
the chemical shifts estimated from the models and the experimental ones. From our 
calculations, it is clear that MetaD can reproduce experimental data rather well (Table 1), 
i.e. with an RMSD comparable with (or even lower than) those that can be calculated for 
structured proteins.97,98,101 This represents a clear and quantitative indication of the ability 
of MetaD simulations to provide an efficient and reliable sampling of the FES and of the 
conformational space of IDPs. To the best of our knowledge, this is the first MetaD-based 
study of an IDP that offers such a quantitative evaluation of the atomic-level reliability of 
the conformational sampling via a very simple and intuitive metrics. 
Two different schemes of population weighting were adopted. One was based on the 
reconstruction of the statistical ensembles following the Boltzmann equilibrium. The other 
was based on geometrical clustering and discarding scarcely populated ensembles. The 
former is derived from the FES binning and the latter from the structural similarity 
between NTAIL conformers. 
 
Sampling Ca Cb C’ HN N 
Clustering 0.887 0.451 0.752 0.213 1.863 
Boltzmann 0.949 0.472 0.902 0.185 1.807 
Kinetic reweighting 0.944 0.442 0.947 0.166 1.686 
Sample and select 0.426 0.484 0.328 0.172 1.578 
 
Table 1. Average Root Mean Square Deviations (RMSDs, in ppm) between Calculated (Using SPARTA+) 
and Experimental Chemical Shifts. Four different methods were compared, as indicated in NMR data 
prediction of the Methods section. 
 
In both cases, there was very good reproduction of the experimental data, with 
deviations generally being very close to each other. This is a reflection of the small free-
energy differences among the most relevant conformations (Figure 10). It suggests that the 
energetic convergence of the simulation (Figure 9) corresponds to an excellent sampling in 
terms of molecular geometry too. Interestingly, for the most structurally informative nuclei 
Cα, Cβ and C', the geometrical clustering provided a better agreement (in terms of RMSD, 
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see Table 1) than the FES binning. This can be explained in terms of suboptimal force field 
performance. Moreover, the great FES roughness, typical for IDPs,105,106 can partially 
influence the accuracy of any binning/clustering procedure used for weighting the 
populations, hence randomly biasing the final result to a small extent. Furthermore, a 
sample-and- select procedure applied to the whole trajectory indicates that it contains the 
core of the chemical information encoded by NMR spectra. This indicates that MetaD can 
be efficiently used as a source of structural information in an SAS procedure stemming 
from the protein FES. Notably, the ability of the SAS based procedure to reproduce 
experimental data supports the use of MetaD to efficiently explore at least the full 
experimentally accessible conformational space of IDPs. 
The absolute chemical shifts calculated according to the four different methods 
mentioned above are compare with the experimental counterparts in Figure 11. As 
expected, good correlations for Cα and Cβ atoms could be obtained, while a slightly noisy 
pattern was found for the carbonyls.  
However, the most relevant probes for capturing details about the structure and 
dynamics along the sequence are the secondary structure chemical shifts (ss in the present 
text, i.e. the difference between the computed or measured δ and its value in the random 
coil). 
 
 
Figure 11. Absolute Chemical shifts for the Ca (left panel), C’ (central panel) and Cb (right panel) atoms of 
NTAIL. Results from the calculations on the clustered trajectory (red, circles), the Boltzmann weighted 
trajectory (blue, diamonds), the kinetic ensembles (green, triangles) and the conformational selection 
procedure (maroon, triangles) are compared to the experimental values (black, squares). 
 
In our calculations (Figure 12), ssCα and ssC' exhibit positive values, indicating the 
formation of alpha helical structures throughout the chain, in agreement with the average 
slightly negative value of ssCβ. Notably, all the above-mentioned secondary shifts exhibit a 
significant deviation from the experimental data around residue Alanine 484, 
corresponding to the C terminus of helix H1 (479- 484). Several almost fully helical 
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structures displaying a tilt centred on residues 484-486 are present in the minimum energy 
region (see sample structures reported in Figure 10). This is compatible with the 
discrepancy between the simulated and experimental data. This tilt can be explained by the 
presence of a small three-residue hydrophobic cluster (I483, A484, and M485), with side 
chains that tend to stay closer in space in order to exclude the solvent, consequently 
inducing a higher mobility in the two branches of the chain. Most likely, more demanding 
simulative setup are required to reduce these discrepancies.107  
 
 
Figure 12. Secondary chemical shifts (difference with respect to the corresponding random coil values) for 
the Cα, Cβ, and C′ atoms. Boltzmann weighted (blue) and cluster weighted (red) values, calculated on the 
structures obtained from the MetaD simulations, are compared to the the corresponding experimental data 
(black). For clarity, the NTAIL sequence is also shown above the top panel, along with the a-helical regions 
in states H1, H2 and H3.  
 
While previous experiments succeeded in providing structural information, little is 
known about the dynamics underlying the interconversion between accessible states, which 
is still a major challenge for biophysics. We used the statistics collected in our biased 
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simulations to construct a discrete- states kinetic model of the NTAIL conformational 
ensemble in solution, following the approach in Ref.26 The essential requirements for 
building the kinetic model are a FES and a matrix of diffusion coefficients in a CV-space 
that is not necessarily the same as that used during simulations. We obtained the former 
applying a reweighting scheme as explained in the Kinetic model setup subsection of the 
Methods section, obtaining the FES shown in Figure 13. 
 
 
Figure 13. We employed all of the structures obtained from the MetaD simulation to reweight the FES in the 
two-dimensional space described by the αcont and Δα CVs. To build the kinetic model, a binning procedure 
applying a 40 x 8 grid along the two CVs (αcont and Δα, respectively) was carried out. 
 
To determine the latter, we maximized the likelihood that a given set of plain MD 
trajectories could be reproduced by the kinetic model, whose transition rate matrix is a 
function of the diffusion coefficient itself. The model allowed us to identify the kinetically 
representative conformations of NTAIL and the corresponding rates (kex) between each pair 
of states. MFPTs are defined as the reciprocal of kex. Our kinetic model identified a total of 
six distinct states (states A to F in Figure 14). 
Notably, all the relevant conformations previously identified in experiments78 were 
also identified as major states in dynamic equilibrium in our model. In detail, the RC, H1, 
H2, and H3 conformations corresponded to states A, B, C, and D, respectively, while states 
E and F represented two additional conformations with a significantly high helical 
propensity. The numerical solution of the simplified system, as indicated in the 
Calculation of equilibrium populations subsection of the Methods section of this chapter, 
led to the following populations of the state in the stationary regime: PA = 30.5%, PB = 
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41.4%, PC =19.9%, PD =1.7%, PE =2.4%, PF =4.1%. A fairly good agreement could be 
observed between the obtained values for states A, B, C and D and the corresponding 
values for conformations RC, H1, H2 and H3 from the proposed conformational 
equilibrium in solution for NTAIL.  
 
 
Figure 14. Interconversion between the kinetically representative conformations of NTAIL. The areas of the 
discs are proportional to the equilibrium populations of the states, while the widths of the arrows are 
proportional to the corresponding MFPT. MFPTs (in ns) are indicated on the arrow ends, close to the 
destination state. 
 
Remarkably, we computed kinetic rates that fall above, and are thus in agreement 
with, the regime of fast exchange (kex > 105 s-1) indicated by previous works for the 
interconversion among equilibrium conformations for NTAIL in solution.13 A closer look at 
the kinetic model reported in Figure 14 allows two sub-ensembles of conformations to be 
identified, reflecting different interconversion regimes and thus distinct thermodynamic 
stabilities. The first group, characterized by the fastest transitions, with MFPT values 
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below 200 ns, is represented by states A, B, and C, corresponding to the mostly unfolded 
RC, H1, and H2 conformations, respectively. Conversely, interconversions between the 
remaining states (D, E, and F), possessing a higher alpha helical content, are significantly 
slower, requiring at least 280 ns (D to F transition) to take place. Going from the unfolded 
to the folded sub-ensemble through direct transitions is also much slower than the reverse. 
This is reflected by the consistently higher thermodynamic stability of states A, B, and C 
compared to states D, E, and F. Indeed, the slowest direct unfolding transition (E to A) is 
much faster than the fastest direct folding transition (C to F), with MFPTs of 172 and 303 
ns, respectively. The binding of NTAIL to its molecular target PX, the C-terminal domain of 
the viral phosphoprotein, is accomplished through electrostatically driven interactions.108 
The binding site is a negatively charged cleft on the surface of PX, with which NTAIL 
interacts, adopting conformation H3. In this state, three arginine residues (R482, R486, 
R490, see Figure 6), located at the centre of the helical motif, are positioned on the same 
side of the helix, forming a positively charged counterpart of the PX binding site. It has 
been proposed that achieving the bound state involves a two-step process.13 An encounter 
complex is first formed between PX and NTAIL in the H2 conformation. This subsequently 
evolves into the native bound state by establishing specific electrostatic interactions. This 
framework suggests a coupled folding and binding process, arising from a sequential 
cooperation of the conformational selection and induced fit recognition mechanisms, as 
already observed in previous works on IDPs.109  
In our model and in agreement with previous studies,78 despites being favoured upon 
binding to PX,13 state D (corresponding to conformation H3) is also shown to be accessible 
in the absence of the molecular target. In other words, even though it is intrinsically 
disordered, the NTAIL sequence encodes for the structural determinants required to adopt 
the bound conformation. Moreover, among the unfolded sub-ensembles, state C 
(corresponding to conformation H2) can be easily accessed through both the A and B 
states, which are in rapid dynamic equilibrium. Remarkably, reaching C from state A is 
only slightly more favourable than from state B. This is interesting because it suggests 
there is no preferential route leading to the partially folded state C adopted in the encounter 
complex. It is accessible from the completely unstructured A without necessarily passing 
through state B. 
3.1.4 Conclusions 
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In the present study, we used atomistic simulations to sample conformational states 
visited at equilibrium by NTAIL, an IDP test case,77 free in solution. To the best of our 
knowledge, this is the first time that computational methods have been used to provide 
both thermodynamic and kinetic atomic-level details of an IDP with a quantitative 
comparison between experimental and spectroscopic data. In particular, we determined the 
free-energy landscape of NTAIL and calculated the kinetic rates for interconversion 
between the main free-energy attractors. Our study demonstrates how, despite the current 
limitations, a fairly good agreement with experimental data can be achieved, provided that 
there is an exhaustive sampling of the conformational space. This is encouraging, as it 
points the way to studies aimed at understanding the interaction with molecular targets, 
and eventually developing effective strategies to drug IDPs.110 In particular, our findings 
suggest that MetaD is a particularly suitable methodology for disordered systems that 
present transient structures, also offering the possibility to explore their FES in a form that 
has a strong correlation with experimental data at atomic level. 
 
3.2 TEST CASE 2: b2-AR 
 
3.2.1 Introduction 
 
A major goal in drug discovery is the identification of small molecule ligands that are 
able to bind and modulate the activity of biomolecules involved in a certain, or sometimes 
multiple, pathological conditions. Binding of small molecule ligands is usually represented 
as a two-state, all-or-none process in which the ligand is either free in the bulk or placed in 
a binding site on the molecular target. Ligand binding affinity and binding rates are 
quantitative parameters that are crucial during the drug discovery and development 
process. These parameters depend on the free energy profile of binding. Affinity is 
typically expressed in term of Kd and depends on the free energy difference between bound 
and unbound states, while kinetic rates, namely kon and koff, depend on the free energy 
difference between these states and the transition states, which are pretty elusive and 
difficult to observe (a schematic representation is given in Figure 15). 
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Figure 15. Schematic representation of a two-state model for the protein (P)-ligand (L) binding process. 
Assessing affinity (in terms of Kd) implies determining the difference in free energy between the bound and 
unbound states (∆Gd), which in turn is independent from the route followed from the former (P + L) to the 
latter (PL) state. Conversely, calculating the on- and off- rates (kon and koff, respectively) requires a detailed 
knowledge about the intermediate states visited along the reaction coordinate (x). 
  
In drug discovery and optimization phases, one wishes to achieve a rational 
optimization of these interesting quantities in order to improve drug binding properties.4,6 
Therefore, an accurate prediction of the free energy profile associated to ligand binding is 
of paramount relevance. However, this is still an ambitious goal for modern drug design. 
Additionally, a more complex picture compared to the two-state mechanism can be also 
envisioned, where a series of intermediate, lower energy states are separated by higher 
energy transition states. Complex reaction pathways are difficult to characterize at such 
level of detail through experiments. Therefore, computer simulations, and MD24 in 
particular, can be extremely helpful in this regard as an all-atom description of complex 
processes, including protein-ligand binding, can be provided. In the limit of an ergodic 
simulation, useful insights about transition and metastable states can be extracted and the 
affinity and rates would be determined with high accuracy.  
An increasing number of studies is demonstrating how simulating spontaneous 
binding/unbinding of small molecules to biomolecular targets via unbiased, plain MD 
simulations is becoming more and more viable,111–114 also for systems of considerable size 
such as GPCRs.111 However, the computational resources required are still impressively 
high, and certainly not accessible to most of the current research groups. Furthermore, in 
this scenario, collective proper statistics of such rare events is prohibitive. Enhanced 
sampling methods have been developed to overcome these limitations.16 MetaD25 is one of 
such techniques, and allows an efficient exploration of a system’s phase space guiding the 
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sampling along reaction coordinates representing slow degrees of freedom, the so-called 
CVs. However, identifying appropriate CVs is not trivial and requires the major efforts 
when using MetaD.31 Moreover, this aspect exacerbates when it comes to protein-ligand 
binding, where many, and potentially system-dependent, degrees of freedom, are involved. 
Thus, the path CVs18 have been specifically devised to manage complex reaction 
pathways. The idea is to guide MetaD sampling along a putative pathway representing the 
progression along the reaction, while exploring adjacent regions of the phase space. While 
multiple pathways can be considered, the one in which the minimum free energy lies can 
be recognized. However, as one might expect, providing the required “guess path” is far 
from trivial, as this implies the availability of some sort of information about the process 
we are aiming at studying.  
Herein, we present our strategy to tackle this problem. First of all, we construct a 
MSM17 from available, large-scale plain MD simulations. The model allows identifying 
relevant intermediate states visited by the ligand along its way to the binding site. 
Subsequently, we exploit such states as a template to construct a putative binding pathway, 
as required by the implementation of the path CVs. Taking advantage of such “guess 
path”, our aim is to reconstruct the free energy surface along the binding process through 
path CVs-based MetaD. This would allow us exploring the possible routes accessible to 
the ligand, determining the minimum free energy pathway, and identifying the 
intermediate metastable and transition states visited. 
We applied our procedure to binding of the ligand Alprenolol to the b2-adrenergic 
receptor (b2-AR) (Figure 16). In a recent study, the D. E. Shaw research group reported 10 
binding events for the ligand Dihydroalprenolol and 2 for the ligand Alprenolol.111 While 
in three out of the ten runs from the first group the ionic concentration of Na+ and Cl- was 
specified in order to neutralize the system, in all of the other runs the necessary amount of 
Cl- ions was added only. Accumulating the 12 runs provided a total simulation time of 
about 63 µs. Interestingly, 11 strikingly similar pathways were observed (see Table 2). 
Moreover, while in all of the simulations the ligand was able to reach the orthosteric 
binding site, in 6 of them only the binding pose reported in the crystal of the protein-ligand 
complex (PDB ID: 3NYA, resolution 3.16 Å) was reproduced (RMSD < 0.8 Å). Given the 
very small difference in chemical substituents (Figure 16, right-hand side), both ligands 
Dihydroalprenolol and Alprenolol showed the same interactions with the molecular target 
in the reported simulations as well as and in experimental studies. Therefore, the runs were 
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grouped and analyzed together in the original paper and the ligand was simply referred to 
as Alprenolol. 
 
 
Figure 16. The b2-adrenergic receptor (b2-AR, left-hand side) and the two analogue inhibitors considered 
for the present work (right-hand side). The transmembrane helices towards the reader (I, II, V-VII) are 
labelled for clarity, as well as the extracellular loops (ECL1-3) between the helices; a schematic 
representation of the positioning inside the cellular membrane is also given. The location of the orthosteric 
site is highlighted by the presence of the ligand, shown in the van der Waals drawing method. 2D structures 
of Dihydroalprenolol and Alprenolol are shown on the right; according to the plain MD simulations and 
previously reported experimental data, no relevant difference in the behaviour of the two small molecules 
was observed. Numbering is shown on heavy atoms to help the reader when specific positions of the 
molecule are mentioned in the text. 
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Run Liganda Conditionb Duration (µs) Binding posec 
1 DA N 11 - 
2 DA N 3 √ 
3 DA N 5 √ 
4 DA N 4 √ 
5 DA N 10 - 
6 DA N 5 √ 
7 DA N 9 - 
8 DA I 5 - 
9 DA I 3 √ 
10 DA I 5 - 
11 A N 3 √ 
12 A N 3 - 
 
Table 2. Summary of the available trajectory set, as provided by the D. E. Shaw Research group. a DA stands 
for Dihydroalprenolol, while A for alprenolol. b N designates those systems that have been neutralized by 
adding only the appropriate number of ions of the opposite sign. I indicates instead that the ionic strength 
was set, thus both positively and negatively charged ions were present in the bulk. c Where a √ sign is 
present, the ligand was able to reach the binding pose reported in the crystallographic structure (PDB ID: 
3NYA) with an RMSD < 0.8 Å. 
 
3.2.2 Methods 
 
We used all of the available simulations reported in Table 2 to build a MSM.111 As 
previously mentioned, in only 6 out of 12 runs the authors were able to reproduce the 
binding pose observed in crystal structure of the complex (PDB ID: 3NYA) with an 
RMSD < 0.8 Å. We refer to these simulations as “productive”. However, in all of the 12 
runs the ligand reached the orthosteric site on the b2-AR. In other words, while in the 
remaining cases Alprenolol was able to access the binding site, it remained stuck in 
alternative poses without reproducing the crystallographic one. These are referred to as 
“non-productive” runs. Therefore, we aggregated both productive and non-productive runs 
to construct the model, as information about access to the orthosteric site is guaranteed in 
both cases. In order to reach the site, which lies buried deep inside the bundle of seven 
transmembrane helices, the ligand needed to squeeze through a narrow passage between 
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ECL2 and and helices 5-7. To approach the passage, the so-called extracellular vestibule is 
first occupied, enclosed by ECL2, ECL3 and helices 5-7. 
All of the simulations were started in the unbound state, with 10 replicas of the ligand 
placed in the bulk. Trajectory frames were saved every 180 ps, and included a significant 
amount of time during which ligands wandered in the solvent without accomplishing 
durable contacts with the solvent-exposed surface of the protein. Therefore, in order to 
reduce the amount of data to process, and considering that our goal was to achieve a 
thorough understanding about the behavior of the ligand from the surface to the orthosteric 
site, we discarded these initial, non-relevant parts. Specifically, for each trajectory, we 
defined contacts between the Alprenolol and residues from the b2-AR when the distance 
between heavy atoms was below 5 Å in at least one frame. We then monitored the distance 
relative to such contacts along the trajectory, and discarded those frames in which the 
minimum among the distances recorded was above a 30 Å value. Applying this procedure, 
we gathered a total number of frames equal to 296659.  
In the upcoming sections, we first go through the steps followed to build the MSM for 
Alprenolol binding to the orthosteric site of the b2-AR. Subsequently, we highlight the 
procedure applied to select relevant states along the binding pathway. In order to carry out 
these steps, the software PyEMMA, version 2.4, was used.115 Finally, we describe how we 
constructed the guess path. 
 
3.2.2.1 Choice of the variables 
As already pointed out in the Theory chapter, the first step when constructing a MSM 
is selecting appropriate variables.37 By using the term appropriate, we refer to variables 
that are able to describe the dynamics of interest, and to recognize different states of the 
system relatively to the process under study. In this specific case, the aim was to monitor 
the advancement of Alprenolol along its route from the surface of the protein towards the 
occupation of the orthosteric site.  
A first obvious choice would be considering the RMSD of the ligand after aligning the 
system on the protein a-carbons. However, distinguishing such a plethora of different 
states taking advantage of a single value can be misleading. In particular, similar values of 
RMSD could gather together extremely different configurations of the protein-ligand 
system. Therefore, after considering such option and confirming the expected behavior, we 
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discarded this choice. Another obvious possibility is the distance between the center of 
mass of the ligand with respect to the one adopted in the crystallographic binding pose. 
However, similar issues as for the RMSD were encountered in this case. Specifically, 
different configurations of the ligand can be expected at same values of distance. We 
iterated over several other options, and tested the outcomes in the ability of clustering to 
group together similar states employing different variables and combination of variables. 
Inspired by a previous work in which the authors tackled similar issues,116 we considered 
the minimum distance between protein and ligand heavy atoms. Another aspect, when 
choosing variables, is the desired trade-off between their number and the ability to be good 
variables. Since clustering is going to be applied, the wider the variable space, the highest 
the computational effort required. Moreover, in our experience, using increasing number of 
variables would not necessarily lead to an improvement in the definition of different states, 
and we related this effect to an increase in the overall noise. Therefore, we reduced the 
picture to considering a-carbons only for the protein, and heavy atoms for the ligand. 
Moreover, since the process under investigation involves directly only a fraction of the 
protein residues, we restricted our selection to those belonging to the bulk-exposed surface, 
to the extracellular vestibule, to the narrow passage leading to the binding pocket, and to 
those making up the orthosteric site. Figure 17 gives a pictorial representation of the 64 
protein residues resulting from this selection. As for the ligand, not all of the heavy atoms 
were considered as well. We reduced the selection to the most significant heavy atoms 
needed to describe a relevant configuration of the ligand. Specifically, the two oxygen 
atoms belonging to the phenol ether and the hydroxyl groups respectively, and the nitrogen 
present in the secondary amine group, positively charged at the physiological pH. These 
chemical groups allow the ligand to interact with protein residues by means of hydrogen 
bonds and salt bridges. Additionally, two carbon atoms were selected in order to take into 
account the possibility of having a flip of the phenyl ring while the other chemical groups 
in the small molecule would maintain the same configuration. Following the numbering 
reported in Figure 16, the 5 atoms O14, O17, N19, C11 and C7 were chosen. Therefore, 
320 minimum distances between these two groups of atoms, namely the a-carbons from 
the 64 protein residues selected and the 5 heavy atoms from the ligand, were obtained and 
used as variables for the next steps. 
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Figure 17. Protein residues (highlighted in yellow, all of the corresponding heavy atoms are shown in sticks) 
selected for the calculation of minimum heavy atom distances with respect to the ligand. From these residues, 
the a-carbons only were considered. 
 
3.2.2.2 Clustering of the variables 
After appropriate variables have been defined and their values calculated for each 
frame of the available trajectories, the subsequent phase involves clustering such data. We 
call this step state decomposition,37 meaning that we are dividing the system’s 
configurational space into a set of states (the clusters), referred to as microstates. Since the 
aim is to quantify the transitions between these microstates, in the ideal situation one 
would achieve a kinetic clustering. This would require determining the average transitions 
times between all couples of conformations visited by the system, and defining groups 
basing on such information. In such a scenario, no internal energy barriers would be 
encountered within a microstate and all of the members would interconvert more rapidly 
between them than with respect to any other microstate. However, there is currently no 
way to obtain these average transition times easily and in a straightforward manner. 
Therefore, the typical procedure is to devise a kinetically relevant geometric clustering. 
The idea is that similar configurations in terms of geometry are likely to rapidly 
interconvert. On the one hand, this would become even more likely as we divide the 
configurational space more and more finely. On the other hand, we need to ensure 
sufficient statistics for each microstate, or, in other words, a reasonable population for that 
cluster, in order to determine transition probabilities between the microstates accurately.  
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In order to cluster our data, we employed the K-means clustering algorithm.43,44 We 
emphasize that several clustering algorithms have been devised over the years,117 but no 
general algorithm exists that one can expect a priopri to be effective. Clustering is not an 
application independent problem, it is strictly dependent on the context, and each 
algorithm has its own advantages and disadvantages. As for K-means, it has gained great 
popularity in the MSM community and has been employed with satisfactory results in 
several previous works.40–42 This clustering algorithm tends to locate more clusters in more 
densely sampled regions. This avoids creating too many groups with small counts, thus 
favoring a more accurate determination of the transition probabilities. However, one needs 
to be aware that risks are the over division of certain regions and under division of others. 
When using K-means, the number of clusters needs to be specified by the user. A rule of 
thumb is to use the square root of the number of initial data points. In this case we had 
about 300000 data points, thus resulting in a number of clusters of 500. As stressed in the 
original paper,111 strikingly similar pathways were observed in the binding trajectories. 
Visual inspection confirmed such picture, and we observed a contained amount of states in 
which the ligand stations for a long time. Therefore, we considered reducing the number of 
cluster to as low as possible. We tested increasing number of clusters, specifically 50, 100, 
150, 200, 300, and 500. Since we worked in a 320-dimensional space, we projected the 
corresponding clusters in a more intuitive space in order to assess the quality of the results. 
For each cluster obtained, we calculated the RMSD on the ligand with respect to the 
crystal bound state for all of the configurations contained in that cluster, and took the 
average; similarly, the average distance between the center of mass (COM) of the ligand in 
each configuration of the cluster and in the crystallographic complex was used as a second 
dimension. In Figure 18, the different numbers of clusters considered were projected in 
such space. As shown by the plots, increasing the number of clusters from 50 to 100 and 
150 clearly leads to an improved distribution of the clusters. Conversely, a further 
increment to 200, 300 and 500 does not broaden significantly the distributions, while 
determines instead a finer subdivision of the already considered space. As already 
introduced, we aimed at maintaining the amount of clusters contained. Therefore, we chose 
150 as the number to build our model. 
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Figure 18. Projection of different number of clusters in a 2D space. Distributions of the clusters in the 
considered space do not change significantly increasing their number from 150 to 200, 300 and 500.  
 
3.2.2.3 Lag time selection and Chapman-Kolmogorov test 
Constructing a MSM can be roughly summarized in two major stages. First of all, a 
state decomposition is carried out to define the microstates in the system. This allows 
shifting from the conventional view of trajectories as a series of structures over time to a 
series of microstates over time, the so-called discrete trajectories. Secondly, jumps are 
performed over these discrete trajectories and the corresponding transitions in the 
microstate space recorded and stored in a count matrix, from which a transition probability 
matrix can be eventually derived. A critical element in this picture is the size of such 
jumps, as different count matrices would be obtained as a consequence. As already 
introduced in the Theory chapter, we refer to such element as the lag time of the model. 
Markov time is called the smallest lag time that gives the Markovian behavior.37 Under the 
Markovian assumption, systems are memoryless, meaning that the probability of being in 
the current state only depends on the previous state, and not on all of the preceding ones. In 
this view, transition counts are statistically independent. Assessing the lag time 
dependence of the relaxation time scales implied in the system dynamics has been shown 
to be a useful approach to determine appropriate lag times to ensure memory loss. The 
outcoming plot is usually referred to as ITS plot (Implied Time Scales plot).37,38  
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We monitored the dependence of the time scales of the system on increasing values of 
lag time. The state decomposition phase was repeated three times and the corresponding 
ITS plots determined. As shown in Figure 19, very similar results were obtained. As can be 
observed, the relaxation time scales level off at a value of about 600 steps. As already 
mentioned, when performing the simulations that we subsequently exploited for this work, 
the authors saved trajectory frames every 0.180 ns. Since we did not stride the trajectories, 
1 step corresponds to 0.180 ns. Therefore, our choice of 600 steps corresponded to a lag 
time of about 100 ns.  
 
 
Figure 19. Relaxation time scales as a function of lag time (ITS plots). The results after performing three 
independent state decompositions are reported. In all of the three cases, lag time dependence of the time 
scales ceases after a lag time of about 600 steps.  
 
Notably, in order to carry out the procedure just described above and to produce the 
plots in Figure 19, our first attempt was to aggregate all of the 12 productive and non-
productive trajectories from the original paper.111 However, this did not allow observing 
clear convergence of the relaxation time scales. As such a behavior would typically 
indicate presence of states not adequately sampled, we run through the simulations to 
identify possible sources. Thus, while in 11 out of the 12 simulations the binding pathways 
were extremely similar, we observed one single trajectory in which the ligand got access to 
the orthosteric site through a different route. Therefore, we discarded the trajectory and 
repeated the analysis. This allowed achieving a significant improvement in the ITS plots, 
obtaining the converged plots reported in Figure 19. While this clearly indicates that the 
procedure is extremely sensible and responsive to the input data, we are aware that we 
neglected part of the information. Nevertheless, we do not exclude that other binding 
pathways might be envisaged. Therefore, we decided to focus our view on the most 
frequent route observed in the available simulations without producing additional plain 
MD data. 
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One validation that is typically considered at this point is the Chapman-Kolmogorov 
test (CK test).38 Through this procedure, we evaluate whether the MSM, obtained imposing 
a certain lag time on a discretized phase space, is consistent with the data used to 
parameterize it. In practice, what one does is assessing the probability of remaining within 
an initial microstate after multiples of the lag time used to construct the model. This 
procedure is repeated for MSMs built at increasing values of lag time, and for the original 
MD trajectories. The aim is to determine whether consistency is met between the MSM 
built at the desired lag time and the MD data within statistical error. Herein, we carried out 
the analysis constructing three MSMs, specifically with lag time of 200, 400 and 600 steps. 
As can be seen in Figure 20, an increasing consensus with the plain MD data was found. In 
particular, the MSM built with the chosen lag time of 600 steps lies within the 
uncertainties of the transition probabilities estimated from the MD trajectories. 
 
 
Figure 20. Chapman-Kolmogorov test. The consistency between MSMs constructed at increasing values of 
lag time (200, 400 and 600 steps) and the original MD data (green line, with bars indicating the standard 
error) is evaluated by means of the test. 
 
3.2.2.4 Selection of the relevant states 
We exploited transition path theory (TPT)118,119 to identify relevant states along the 
binding pathway of Alprenolol from the protein surface to the orthosteric site. In order to 
apply TPT, an initial and a final state, typically denoted by the A and B letters, need to be 
indicated. At this stage, we employed the ligand RMSD with respect to the 
crystallographic binding pose. Thus, we chose as initial state the one with the highest 
RMSD, and the one with the lowest as the destination state.  
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We carried out pathway decomposition in order to obtain all possible pathways 
leading from state A to state B. For each pathway, the associated flux was also determined. 
Subsequently, we devised a simple prioritization procedure for the MSM states visited in 
all of the pathways obtained. Specifically, each state was assigned a score basing on the 
number of times it was observed in the ensemble of possible pathways, weighting for the 
fluxes associated to these pathways: 
 𝑓𝑠 = ∑ 𝑓:>,w 𝑓:>,ZÅZ⁄£wjT   (51) 
  
where the summation runs over all of the possible pathways i in which the considered state 
is present, fAB,tot is the total flux related to the transition A to B, and fAB,i is the flux 
associated to pathway i. Through this analysis, the top ranking states were identified. It is 
worth noticing that centroids are defined by the K-means clustering algorithm as averages 
over the variables values possessed by all of the states gathered in each cluster. While it 
has the clear advantage of generating centroids that are representative of the clusters, this 
does not necessarily correspond to physically meaningful states. Therefore, the mdtraj 
software120 was employed to extract representative configurations from the top ranking 
microstates. Specifically, those structures possessing the lowest RMSD with respect to any 
other one contained in the same cluster were selected as centroids. 
 
3.2.2.5 Construction of the guess path 
In order to use the path CVs, a frameset representing a putative pathway needs to be 
provided.18 The series of frames catches the system at intermediate states along the process 
of interest, namely ligand binding in the present case. An essential requirement is equal 
spacing in terms of RMSD between these subsequent snapshots. Accordingly, including 
more frames has the effect of reducing such distance, thus increasing the resolution of the 
output free energy.  
Obviously, few states would not be sufficient to reconstruct an accurate FES of the 
complex process we were facing. Considering the states that we extracted basing on 
information from the MSM, the RMSD distances between subsequent frames were 
respectively 5.8 Å, 7.7 Å, 7.2 Å, 1.2 Å and 2.5 Å. First of all, significant distances were 
present amongst some of the states, thus inevitably affecting the resolution of the FES. 
Secondly, they did not guarantee the equal spacing required. Therefore, we devised a 
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multi-step procedure in which we first enrich the amount of configurations and 
subsequently select equally spaced frames.  
In order to achieve the desired enrichment, we performed a series of steered MD28,29 
simulations starting in each one of the identified states. As parameters for the protein and 
the ligand could not be transferred from the original topology, the entire system was re-
parameterized. Both protein and lipids were modeled according to the Amber ff14,121 in 
which Lipid 14122 is comprised to describe the latter. Ligand parameters were taken from 
the general Amber force field (GAFF)123 and charges were assigned following the typical 
RESP procedure.124 In each of the steered MD runs between two of the subsequent states 
identified through the MSM, the RSMD was used as CV and targeted to 0. Moreover, one 
additional run was carried out from the first point. In this case, we acted increasing the 
coordination of the ligand by water molecules in order to obtain additional points with 
fully solvated states. We then reverted this first short trajectory and merged it with the 
other steered MD runs, resulting in a 30 ns-long binding trajectory. For the resulting 6 
runs, 5 ns-long each, force constants ranging from 20 to 50 kcal/(mol Å2) were applied. 
The work required was monitored and each run was repeated multiple times to ensure 
reproducibility of the outcomes. As expected, since ligand configurational space from the 
surface to the orthosteric site was relatively limited, all the RMSD-based runs were 
extremely similar. Sample work profiles from the runs are reported in Figure 21B. 
Conversely, as shown in Figure 21A, increasing the solvation of the ligand while detaching 
from the protein opened the way to a variety of states, less relevant for the purposes of our 
study. Therefore, amongst the runs characterized by lower work, we selected in this case 
the one in which it was minimum. All simulations were carried out by means of the 
GROMACS MD engine, version 4.6.7,93 patched with the PLUMED software, version 
2.1.1,94 in order to perform steered MD. 
Once the 30 ns binding trajectory was obtained, we proceeded to selection of equally 
spaced frames in terms of RMSD. Our aim was a spacing of about 1 Å, thus allowing to 
distinguish relatively close states along the binding pathway and to achieve a reasonable 
resolution of the outcoming FES. This was a non-trivial step, as required iterating until the 
initial amount of 13000 frames was reduced to a more contained number, and the desired 
spacing was achieved at the same time. At this stage, we took advantage of a script wrote 
by the path CVs developer, specifically devised for this purpose. Once an input trajectory 
with N frames is provided and the user specifies the number M of output states, the script 
iterates until the best selection among the available frames is found. 
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Figure 21. Work profiles from the performed steered MD simulations. A) Ligand coordination by water 
molecules was increased during the first step, in order to enrich with completely solvated states of 
Alprenolol. Different profiles (work run 1-5) were obtained, thus the one requiring the least work was 
retained for subsequent analysis. B) First (left panel) and last (right panel) steered MD runs using as CV the 
RMSD with respect to the subsequent state. 
 
Figure 22 compares the RMSD between subsequent frames obtained from the first and 
the last iteration steps. As shown in the x axis of the figure, this allowed us selecting 80 
states separated by 1.25 Å.  
It is worth noticing that a requirement for the script is that the states in the input 
trajectory need to be already sequential. However, this is not obvious, as even in a steered 
MD run the system is able to fluctuate around a specific region of phase space and revisit 
it. This was particularly likely in our case, in which we considered the least aggressive 
force constants as possible to guide the ligand. Therefore, we devised an in-house script to 
solve this issue and remove from the steered MD simulation the mentioned loops. After 
applying this procedure, we gathered 110 frames that uniquely represented the 
advancement of the ligand in the 30 ns-long steered MD trajectory. However, such amount 
was not sufficient to guarantee that equally spaced, subsequent frames were present and 
could be identified by the method described above. 
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Figure 22. RMSD between subsequent structures calculated over the 80 frames comprised in the frameset. 
At the beginning of the procedure, 80 among all of the available frames were selected. This initial arbitrary 
choice returned significantly different values of RMSD between subsequent frames (red line). After a certain 
number of iterations, frames for which the spacing was as close as possible were identified (black line). 
 
Therefore, we took advantage of a well-established interpolation method, the Catmull-
Rom splines,125 to use the 110 frames as control point and add intermediate frames in 
between. It is not our purpose to go into details about this interpolation technique herein, 
interested readers are exhorted to find more exhaustive material in the literature. The 
outcome of this pipeline was a set comprising 1091 frames, to which we applied the 
procedure described above in order to extract the guess path made up of the 1.25 Å-spaced 
80 states. 
 
3.2.3 Results and discussion 
 
We aggregated available plain MD simulations for Alprenolol binding to the b2-AR in 
order to build a MSM of the process. To this end, as already introduced in the Methods 
sections, we selected 11 out of the 12 binding simulations as extremely similar pathways 
were observed. In order to construct a count matrix of the transitions in the discrete 
trajectory space, we selected a lag time of 600 steps from the ITS plots. Since 1 trajectory 
step is equal to 0.180 ns, this corresponded to a lag time of about 100 ns. By storing the 
transitions in the count matrix and subsequently determining the corresponding transition 
probability matrix, we built our MSM for the protein-ligand binding process. Starting from 
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the 150 microstates defined through clustering in the state decomposition phase, 93 % was 
the fraction of retained states in the MSM, corresponding to 140 states. It is worth pointing 
out that, despites the aggregated MD trajectories reached a simulation time of about 60 µs, 
the corresponding sampling for the binding process is extremely limited, as 12 events do 
not guarantee adequate statistics for such a complex process, for which multiple pathways 
might also be envisaged. Moreover, runs were stopped once the ligand reached the 
crystallographic pose, thus no unbinding neither re-binding were observed. Nevertheless, 
taking advantage of the 11 similar pathways, we were able to construct a non-reversible 
model for the considered binding process. The obtained MSM is shown in Figure 23, 
projected in a 2D space.  
 
 
Figure 23. Markov State Model obtained for Alprenolol binding to the b2-AR. Circle sizes are proportional 
to the MSM microstate population, while black arrows indicate possible transitions between the states. The 6 
structures in the insets represent the relevant states along the ligand route from the protein surface (top right-
hand side of the model) to the binding site (bottom left-hand side) that have been selected by means of TPT, 
according to the procedure described in the Methods section. 
 
Notably, each microstate was defined by 320 variables, representing minimum 
distances between heavy atoms from specific protein residues and from the ligand. Thus, in 
order to interpret the outcome more easily, we projected the model in a more intuitive 
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space. Specifically, we calculated the average RMSD of the ligand with respect to the 
crystallographic binding pose from all of the configurations contained in each MSM 
microstate, and, similarly, we took the average distance between the center of mass (COM) 
of the ligand in each configuration of the MSM states and in the crystallographic complex. 
Configurations in which the ligand was located on the protein surface were found on the 
top right-hand corner of the plot, while, on the bottom left-hand one, MSM states were 
located in the orthosteric site. As can be observed, at same distances along the binding 
pathway, different values of RMSD are possible. Clearly, this meant that the ligand was 
able to station in same regions while adopting significantly different configurations. 
Following the strategy described in the Methods section, MSM states that were visited 
more frequently by the ligand on its way to the orthosteric site were identified. Shown in 
the insets of Figure 23 are the corresponding configurations, which were subsequently 
employed as a template to construct the guess path. Remarkably, all of the metastable 
states recognized in the original paper111 were caught following our procedure. 
Specifically, such agreement refers in Figure 23 to poses 2 and 3, in which the ligand 
approached and occupied the extracellular vestibule, and pose 4, located at approximately 
the half way between the extracellular vestibule and the orthosteric site. Interestingly 
herein, besides pose 1, that represented an arbitrary state on the surface, almost completely 
surrounded by water molecules, we identified pose 5, in which the hydroxyl group was 
captured while reorienting from state 4 towards the final bound state 6. It is worth noticing 
that specific interactions stabilized each of the states identified. This was in support of their 
relevance in the binding process. 
The 6 states were employed as starting points for the construction of a guess path. As 
already stressed, the latter was required in order to exploit the implementation of the path 
CVs. The resulting putative pathway, that is essentially a frameset describing a likely 
binding pathway according to the input data, comprised 80 equally spaced structures. As a 
result of the RMSD matrix optimization procedure, the distance between each subsequent 
structure was 1.25 Å in terms of RMSD.  
In order to validate the quality of the reconstructed guess path, we projected all of the 
plain MD trajectories used to build the MSM in the space defined by the path CVs, namely 
the s and z variables. The result is shown in Figure 24, where different colors in a scale 
going from black to light gray identify the different input trajectories. As already 
introduced, through the s variable we monitor the progress of our system along the 
frameset. In other words, at a certain simulation step, the value returned by this variable is 
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going to identify the index of the closest among all of the available frames in the guess 
path. Therefore, since we had 80 structures in the guess path, the allowed values went from 
1 to 80. The z variable, instead, is a measure of the distance from the frameset, calculated 
in terms of MSD and thus expressed in Å2. For a more intuitive interpretation, we showed 
the square root of z in Figure 24. For easier reading, from now on in the text, we are going 
to discuss about z values in terms of Å, implicitly referring to the square root of the real 
values of z. In practice, for a certain state of our system, with a combination of the s and z 
variable we determine respectively which frame in the frameset is the most similar to the 
current state and quantify how actually similar is the system with respect to that frame. The 
purpose of this strategy is to also take into account states that are relatively far from the 
guess path, and, since the associated free energy is characterized by MetaD, to detect the 
minimum free energy route for going from frame 1 to 80. According to the projection 
showed in Figure 24, most of the plain MD data was located at low z values. This indicated 
that the constructed guess path represented very well the regions of the phase space visited 
by the original data. As expected, part of the data was placed farther away, reaching values 
of z as large as 7 Å and up to 12 Å. While, as already stressed, the pathways leading to the 
orthosteric site were extremely similar, some of the trajectories did not achieve the 
crystallographic binding pose and featured different states in which the ligand stationed for 
a significant amount of time. Indeed, the regions observed at higher values of z reflected 
such behavior. 
Moreover, we also projected on the path CVs space the 6 states that were used as a 
template to construct the frameset. They are shown as larger white dots in Figure 24, and 
are numbered accordingly to Figure 23. As can be observed, all of the 6 states lied very 
close to the guess path, as they were characterized by low values of the z variable. This 
finding was very encouraging, as indicated that the guess path was well parameterized on 
the states used as a template. 
In order to give a quick overview and interpretation, we subdivided the plot in two 
major areas. A left side that comprised the regions labeled as bulk and surface, and the 
right side that included those indicated as extracellular vestibule and site. Points belonging 
to the left side were more spread. Before achieving contacts with the extracellular 
vestibule, the ligand lacked of stable interactions with protein residues and was from 
completely to partially solvated by water molecules. As a result, the accessible phase space 
was extremely wide and no specific configurations appeared to be particularly favored. 
Conversely, as the extracellular vestibule was approached by the ligand, the configurations 
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were more concentrated in specific regions. Moreover, once the orthosteric site was 
reached, most of the trajectories lied very close and within a 4 Å distance from the guess 
path, highlighting high similarity in the visited phase space. 
 
 
Figure 24. Projection of the original plain MD trajectories on the path CVs space. For an easier 
interpretation, the square root of z, in Å and equivalent to RMSD, is shown on the y axis instead of the real 
MSD values in Å2. Right above the plot, a gross indication of the ligand position (bulk, surface, extracellular 
vestibule, site) in correspondence of s values is given. Each colour, from black to light grey, identifies one of 
the 11 different trajectories used to build the MSM. The larger white dots, labelled by numbers from 1 to 6, 
are the projection of the 6 states used as templates to construct the frameset. At the very top, structures 
labelled by letters A, B, C and D are shown for sample, more concentrated regions of the CVs space. 
 
Shifting to a more practical perspective, the z variable is typically assigned an upper 
wall during MetaD simulations, meaning that sampling is confined within a certain value 
along this variable. In particular, in previous applications, it has been common practice to 
allow for a maximum value of 3 Å (corresponding to 9 Å2 for the real values of the 
variable). For the purposes of this work, in order to include the largest amount of sampled 
regions in plain MD, a value of 4 Å would be more appropriate. While one might be 
tempted to include larger regions of the CVs space, allowing for sampling to larger z, this 
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choice is not free of drawbacks and inevitably exhibits pathologies. First of all, this 
obviously would translate into a significantly more demanding setup in terms of 
computational cost. Secondly, approaching higher values of z, we start loosing the 
resolution that we aim at achieving in the resulting free energy surface. Focusing our 
attention on the regions with z higher than 4 Å in the plot reported in Figure 24, we can 
observe that points tend to be compressed and to form narrow lines in the CV space. This 
is an unavoidable behavior, as the consequence of going significantly farther away from 
the reference path is that different conformations are going to be assigned to a same s 
value, thus creating the observed lines.  
In order to assess the effect of limiting sampling at a maximum of 4 Å for z, we back-
tracked the states belonging to the more concentrated regions observed in the plot. Sample 
corresponding configurations are shown explicitly at the top of Figure 24. In particular, 
state C, that we expected to be a reasonable state to be visited along the way from states 3 
to 4 (highlighted by the white dots and labeled with the corresponding number, 
accordingly) lied within the 4 Å range that we aimed at considering for our production 
phase. State B, where the ligand is flipped completely with respect to the orientation 
assumed in the guess path, would be also considered with such setup. This was particularly 
exciting in the perspective of possibly including, in the outcoming free energy, pathways 
that differ significantly from the parameterized one. States A and D, also very different 
from the configurations included in the guess path, lied instead over the 4 Å cutoff. As a 
consequence, by employing such cutoff, these sates would reasonably be excluded from 
sampling in the subsequent MetaD production phase. 
The above setup is going to be exploited to reconstruct the free energy surface of the 
protein-ligand binding process, namely Alprenolol binding to the b2-AR. To this end, path 
CVs-based MetaD is going to be performed. From the free energy landscape, information 
about alternative binding routes, also relatively far away from the guess path, is going to be 
provided and the one associated to the minimum free energy determined. Structural 
features of metastable states can be extracted and, potentially, transition states between 
these relevant free energy minima can be recognized. In theory, besides energetics, insights 
about kinetics can be also achieved. Provided that the transition states are appropriately 
sampled and the related energy barriers accurately determined, and introducing some 
approximations for a reliable estimate of the pre-exponential factor, kinetic rates can be 
eventually computed. 
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3.2.4 Conclusions 
 
In this study, we laid the ground for the estimation of the free energy profile 
associated to a protein-ligand binding process through computer simulation. Determining 
the FES for a complex reaction, such as a binding process, can be achieved by means of 
the path CVs. These CVs guide the sampling along, and around, a “guess path” that needs 
to be provided as input to the enhanced sampling engine.18 This is essentially a frameset of 
the system captured at intermediate steps along the process under investigation. Herein, we 
constructed a guess path for Alprenolol binding to the b2-AR,111 in order to use it for 
subsequent path CVs-based MetaD simulations. MetaD would allow calculating the 
desired FES. However, in order to built the needed putative pathway, some sort of 
indication about the process is necessary. To this end, we took advantage of plain MD 
simulations carried out in the D. E. research group for the spontaneous binding of 
Alprenolol to the b2-AR.111 Basing on the available data, we constructed a MSM for the 
protein-ligand binding process, and determined the most relevant states. Notably, most of 
these corresponded to the ones suggested in the original paper. Once the relevant states 
were identified, they were used as template to build a guess path. Finally, we projected 
both the relevant states from the MSM and the plain MD trajectories into the path CVs 
space in order to validate our parameterization. The result was promising, with the relevant 
states located at low values of the z variable, and most of the plain MD trajectories, 
notably those with strikingly similar features, placed within the limit of z that could be 
affordable in the subsequent MetaD production phase. 
 
3.3 TEST CASE 3: hDAAO 
 
3.3.1 Introduction 
 
In a typical drug discovery pipeline, after promising scaffolds are identified and 
selected in the hit identification phase, in the subsequent optimization step one aims at 
improving pharmacokinetic and pharmacodynamic properties. These include for instance 
absorption and distribution in the former case, and binding affinity in the latter. 
Traditionally, the affinity of a potential drug, generally speaking a ligand, towards a 
pharmacological target has been expressed in terms of Kd, the dissociation constant, or 
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IC50, the drug concentration leading to the half-maximal inhibition of a biological activity. 
However, there has been a shift of perspective over the last decade, as the importance of 
kinetic quantities has become increasingly evident.4–6 Specifically, we refer to kon and koff, 
the association and dissociation rate constants, respectively.4 However, most of the focus 
has been directed to koff, as this is directly related to drug residence time, which is 
expressed as the inverse of the kinetic parameter.5,10 While the critical significance of 
binding affinity as an estimate of drug potency remains doubtless, there are cases in which 
integrating such information with residence time is more convenient. For instance, this is 
particularly true when the duration of the pharmacological effect plays a substantial role in 
in vivo efficacy.5 In this view, it is clear why possibly achieving a rational optimization of 
the kinetic properties becomes extremely desired. 
During the drug optimization phase, the classic framework would require 
synthesizing, or in the best scenario purchasing, analogs of the scaffold under study, and 
subsequently performing biological assays in order to estimate affinity and kinetic 
properties. Several experimental techniques, such as SPR,126 NMR127 and fluorescence 
methods,128 have become established tools to characterize kinetic features and determine 
kinetic parameters.129 However, being able to integrate or potentially replace completely 
this procedure with a computational approach would have the effect of improving 
considerably the efficiency, not to say the accessibility, of the optimization strategy. From 
the computational standpoint, this would require assessing the atomic-level determinants 
underlying binding and unbinding kinetics. The more appropriate approach would demand 
for MD simulations of the entire binding and unbinding processes. However, besides being 
not straightforward, the application of MD to this type of problems neither would be 
efficient. As already stressed out abundantly, most of the limitation lies inside the 
timescales problem. Undoubtedly, enhanced sampling methods16 are currently the most 
effective and promising tools to sample, and thus to achieve information about, slow 
events. Nevertheless, by means of the current frameworks and considering that 
computational resources are typically limited, we can aim at managing one to a few ligands 
at the time. In addition, such procedures do not provide outcomes in a timely manner, as 
usually requested in an optimization phase. 
Recently, a more practical and accessible methodology has been introduced to tackle 
the limitations described above.21 In particular, the focus is on residence time, the inverse 
of the dissociation rate constant.5 Instead of aiming at calculating absolute values for 
kinetic observables, the goal is being able to rank ligands according to their residence time. 
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Once this is achieved, ligands can be classified and distinguished in faster and slower in 
terms of unbinding simulation time.21,130 Slower ligands would then be selected for further 
improvements. As discussed in detail in the Theory chapter, the methodology is based on 
scaled MD,19,20 as it allows observing unbinding events at considerably more accessible 
computational costs. 
Herein, we applied the ranking procedure to human D-amino acid oxidase (hDAAO). 
The flavoprotein hDAAO catalyzes the oxidative deamination of D-amino acids with 
excellent stereospecificity.131 Firstly, the enzyme oxidizes the substrate with the 
concomitant reduction of a molecule of FAD, which acts as a cofactor; secondly, the 
produced imino acid is released into the solvent, where it non-enzymatically hydrolyzes 
into the corresponding α-keto acid and ammonia. A schematic representation of the 
mechanism is given in Figure 25. 
 
 
Figure 25. Mechanism of the D-serine oxidative deamination catalysed by hDAAO. Adapted from Ref.131 
 
In humans, the enzyme is mainly present in liver and kidney, where it detoxifies D-
amino acids from dietary and bacterial origin,132 and in several regions of the brain, from 
cerebellum to frontal cortex, where it is involved in regulation of D-serine levels.133–135 In 
the central neuronal system, the amino acid D-serine acts as a synaptic co-agonist at the 
NR1 subunit of the N-methyl-D-aspartate receptors (NMDARs), activation of which is 
associated with synaptic plasticity, learning and memory, and pain sensation.136 From a 
pharmacological standpoint, D-serine dependent, aberrant NMDARs activity is involved in 
several neurological diseases. In particular, it has been highlighted that the lowered activity 
of the receptors is associated to psychiatric disorders, such as schizophrenia137 and 
neuropathic pain.138 The role of hDAAO in the brain was unknown until recently, when 
reciprocal correlation between D-serine and hDAAO concentration was demonstrated, 
suggesting the involvement of the enzyme in the metabolism of the neuromodulator.133–135 
Therefore, by increasing D-serine levels and thus activation of NMDARs, inhibition of 
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hDAAO has been proposed as a potential effective therapeutic approach. Since 
determination of the crystal structure in 2006, many efforts have been focused on 
development of potent inhibitors of the enzyme.137  
Inspired by the result of a previous virtual screening campaign carried out in our 
laboratory, we selected among the reported compounds those that shared a chemical 
scaffold. Without any a priori knowledge of kinetic properties, we prioritized the 
compounds according to the computational time of unbinding from our simulations. 
Subsequently, kinetic data were produced and compared with the predicted values. The 
outcoming picture showed a good agreement between simulation and experiments. 
Moreover, from the analysis of our scaled MD trajectories, we were able to identify two 
major conformations for the loop located at the entrance of the hDAAO binding site.139,140  
 
3.3.2 Methods 
 
A first virtual screening campaign carried out in our lab, and aimed at identifying 
inhibitors of hDAAO, led to the purchase of 24 chemical compounds. Among these, 6 
active compounds were identified in the µM regime. The goal was a competitive inhibition 
by targeting the protein binding pocket, where the oxidation of the substrate takes place 
through reduction of a molecule of the FAD cofactor.131 The activity of the ligands 
identified ranged from about 10 to about 500 µM. Basing on these results, purchasable 
analogs of the compounds were searched by means of the SciFinder engine.141 Thus, other 
19 chemicals were gathered and activity assays performed. Scaffolds already reported in 
the literature were present among all of the selected compounds. However, no data were 
previously reported for the molecules considered in the virtual screening campaign. From 
the assays, no significant improvements were observed. Nevertheless, a group comprising 
4 of the compounds was particularly interesting, as minor differences in chemical 
substituents were responsible for considerably different values of activity. Moreover, while 
IC50 values were available, no information about kinetic properties was provided. Inspired 
by all of these factors, we considered applying the ranking procedure reported in previous 
studies in order to prioritize these compounds in terms of unbinding simulation times.21 
One important aspect when applying the mentioned procedure is that, as a starting point for 
the scaled MD simulations, the structures of the ligands in complex with the protein are 
needed. In the literature, no crystal structure of hDAAO in complex with the scaffold 
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representing the selected compounds was reported. However, the crystal for a closely 
related small molecule was available. While the scaffold was different, the portion giving 
the core interactions was perfectly identical. Therefore, such crystal structure was 
employed as a template to position the ligands inside the binding pocket. As the scaffold 
without any substituent was previously reported in the literature,142 we added it to the 
group of the considered compounds. Therefore, the 5 small molecules reported in Figure 
26 were eventually considered.  
 
 
Figure 26. Structure of the compounds chosen for scaled MD simulations. 
 
3.3.2.1 Simulation setup 
As a first step, the complexes between ligands and hDAAO needed to be constructed. 
As already mentioned, no crystal structure was available in the Protein Data Bank (PDB) 
for the protein in complex with ligands possessing a common scaffold with the chosen 
compounds. Therefore, we took advantage of a closely related small molecule for which 
the PDB in complex with hDAAO was present (PDB ID: 3CUK, resolution 2.49 Å). The 
structure of the compound is reported in Figure 27B and compared with the common 
scaffold found for the 5 compounds. Focus on the binding site and the main interactions 
with the protein are also reported in Figure 27A. As shown in the Figure, the pyrrole-2-
carboxylic acid moiety is responsible for all of the most significant interactions with the 
target. All of the chosen ligands maintained the identical moiety, thus we expected the 
same interactions to take place. Therefore, using 3CUK as a template, we created the 
complexes for our chemicals by placing them in hDAAO binding site with the Cartesian 
coordinates of the common moiety perfectly overlapping. The resulting superposition is 
shown in Figure 27C. Once the protein-ligand complexes were constructed, each system 
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was solvated in a cubic box with TIP3P water molecules.88 In order to neutralize the 
overall charge, an adequate number of Na+ ions was added. 
 
 
Figure 27. Creating the hDAAO-ligand complexes. A) Bound state for the crystal structure 3CUK. The 
ligand is packed between the flavin from FAD and the side-chain phenol from Tyr 224 (left panel). The 
pyrrol-2-carboxyl group gives rise to two hydrogen bonds, one with LYS313 and the other with TYR228, 
and a salt bridge, specifically with ARG283 (right panel). Such features are preserved in several PDBs for the 
protein in complex with different inhibitors. B) 2D structures for the ligand found in PDB 3CUK (top) and 
for the scaffold of the ligands selected for scaled MD simulations. The structures are shown for comparison. 
C) Superposition of the considered scaffold on the ligand of the 3CUK complex (shown as transparent). 
 
The Amber ff99SB-ILDN80,143 was employed for the protein, while the ligands were 
modeled according to the GAFF,123 following the RESP procedure124 to determine the 
charges. As already mentioned, substrate oxidation by hDAAO is concomitant with the 
reduction of a molecule of the FAD cofactor.131 Notably, the cofactor flavin group is 
located at the very bottom of the substrate binding pocket. In all of the crystal complexes 
reported in the literature, the group is in close vicinity of ligands and it is oriented such as 
to give rise to a pi-pi stacking interaction with them. Therefore, we needed to include it in 
our system. Cofactors are usually composite molecules, typically comprising diverse 
chemical groups with different properties, as is the case for FAD. Moreover, due to their 
relatively large size, they are characterized by many degrees of freedom. Thus, deriving 
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proper, as to say reliable, parameters for such chemical species is far from trivial. For the 
present case, we took parameters for the FAD cofactor from the R.E.DD.B. database, 
where multiple conformations of each building blocks comprised in the molecules are 
considered in the systematic procedure followed to derive charges.144  
According to the classic pipeline for system preparation, we first minimized and 
subsequently equilibrated each protein-ligand complex. In particular, position restraints of 
about 2.4 kcal/(mol Å2) were first applied to all system heavy atoms and then to a-carbons 
and FAD and ligand heavy atoms in two subsequent steepest descent runs, 5000 step-long 
each. After this, during the equilibration phase, temperature was first increased in the NVT 
ensemble in three subsequent steps lasting 200 ps each. This was followed by a 400 ps-
long run in NPT to relax the volume and, finally, a 500 ps run in the NVT ensemble were 
carried out under the same conditions employed for the subsequent production phase. 
We took advantage of a GROMACS 4.6.1 version93 appropriately modified in-house 
in order to perform scaled MD. As described extensively in the Theory chapter, under 
scaled MD conditions the PES of the system is scaled by a factor l, where 0<l<1.19 On the 
one hand, this has the effect of facilitating transitions along all of the degrees of freedom 
comprised in the system, in a similar way as simulating at high temperatures would do. On 
the other hand, a major drawback is that system stability is compromised as one applies 
lower, thus more aggressive, scaling factor values. More precisely, the secondary, and 
consequently the tertiary, structure of proteins tends to be disrupted. As a practical 
solution, the authors of the methodology applied weak position restraints in non-relevant 
regions of the considered protein. Specifically, values as low as 0.12 kcal/(mol Å2) on 
backbone heavy atoms were sufficient to maintain protein structural features when a l 
value of 0.4 was employed.21,130 To choose a convenient scaling factor for our simulation, 
we performed some test runs on the fastest and slowest ligand at increasing l values, such 
as 0.4, 0.45, 0.5 and 0.6. We note that values as low as 0.4 and 0.5 were applied in the 
previous works. In particular, in one of these cases,130 it was shown that a significant 
improvement in ligand discrimination was achieved when repeating the procedure at the 
higher value of 0.5. While this was reasonable, as the effect on the PES responds to an 
exponential dependence, it translated into a considerably increased computational effort. It 
is worth noticing at this stage that no rule exists to determine the more appropriate scaling 
factor. While the method can be considered general as it affects the entire system, the 
choice of the l factor is not. In our test runs, we were able to obtain a satisfactory 
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separation between the fastest and the slowest ligand, falling within the 100 ns range, when 
a scaling factor of 0.45 was employed. Therefore, such value was used to perform all of 
our scaled MD simulations. For what concerned the position restraints, taking the already 
mentioned crystal structure 3CUK as a reference, we selected those residues that were 
farther than a 6 Å distance from the ligand. All of the residues comprised in the loop 
located at the entrance of the binding site (residues 216 to 228)139,140 were also excluded 
from the selection. Moreover, as the flavin ring from FAD was in close vicinity of the 
ligand, no restraints were set on it. As indicated in the previous works,21,130 0.12 kcal/(mol 
Å2) weak restraints were applied to the backbone heavy atoms from the selected residues. 
Figure 28 gives a pictorial representation of the unrestrained regions of the protein. 
 
 
Figure 28. In order to preserve the overall protein structure, weak position restraints were applied to regions 
located far away from the binding site. In red colour, residues on which no restraints were set are highlighted.  
 
Production runs were started from the final frame obtained in the last equilibration 
step, carried out in the NVT ensemble. For each simulation, initial velocities were 
randomized. In order to assess unbinding, the distance between ligand and pocket centers 
of mass was monitored as a function of the simulation time. When the distance reached a 
value of 30 Å, the run was stopped and the corresponding simulation time recorded. At 
such distances, ligand could be considered fully solvated and detached from the protein.21 
We considered such state as achieved unbinding. In case the protein-ligand complexes 
were not dissociated within 100 ns, the run was also terminated. As the major goal of this 
procedure was efficiency, we decided to contain the computational effort so as to be as low 
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as possible. Notably, no unbinding within the 100 ns took place more often for the slowest 
ligand only. For each of the 5 considered small molecules reported in Figure 26, we carried 
out 18 scaled MD simulations and recorder the computational unbinding times. We then 
took the mean of the values registered in order to rank the ligands according to their 
propensity to leave the binding site.  
 
3.3.2.2 Enzymatic assays 
Once the scaled MD simulations were performed, the compounds were purchased and 
experimental assays performed by our colleague Elena Rosini at The Protein Factory, 
Politecnico di Milano, ICMR-CNR, Università degli studi dell’Insubria.  
To determine IC50 values, an Amplex Red-based assay has been utilized. This allowed 
measuring hDAAO product formation and thus determining the inhibitory activity for the 
compounds under investigation. hDAAO, horseradish peroxidase (HRP), FAD, as long as 
the considered compound were incubated for 30 minutes. After this pre-incubation period, 
D-serine and Amplex Red were added and the reaction proceeded for 30 additional 
minutes. A fluorescent product caused by hydrogen peroxide-dependent Amplex Red 
oxidation during hDAAO-catalyzed substrate turnover was measured in endpoint mode 
(excitation and emission wavelengths of 530 and 590 nm, respectively). The final 
concentration for the reactive components were as follows: 50 mM sodium phosphate, pH 
7.4, 0.06 mg/mL human serum albumin, 7 nM His-hDAAO, 0.1 units/mL HRP, 4 µM 
FAD, 35 µM Amplex Red, 5mM D-serine, 0.8% (w/v) dimethyl sulfoxide (DMSO), 0-1.25 
mM compound inhibitor. All enzymatic assays were conducted at room temperature in 96-
well plate format. Data were fit to a standard, four parameters equation to determine curve 
top, bottom, concentration producing 50% inhibition (the IC50) and hill slope. 
Equilibrium binding constants were determined via absorption spectroscopy. The 
binding of the different small molecules was investigated by adding increasing 
concentrations of the ligand to a fixed amount of hDAAO (10 µM) in presence of 4 µM 
free FAD in 50 mM potassium phosphate buffer, pH equal to 7.5, and at 15 ºC. Absorption 
spectra were collected in the 300-800 nm range. The dissociation constant Kd, hereafter 
referred to as static Kd, was determined from the change in absorbance at about 492-494 
nm in response of increasing ligand concentrations. 
Association and dissociation kinetic constants kon and koff were calculated by means of 
stopped flow spectrophotometry. The dynamic dissociation constant, expressed as dynamic 
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Kd, was also determined from the ratio of the obtained values of the kinetic rates. Under 
the same experimental conditions as indicated in the previous paragraph, hDAAO (1.1 
mg/mL) was rapidly mixed in a SFM-300 Biologic apparatus with a similar volume of 
increasing concentrations of inhibitor. The time course of spectral changes was recorder in 
the 300-700 nm wavelength range, and the absorbance versus time data sets were 
extrapolated at the wavelength identified by static titrations. Observed rate constants (kobs) 
at increasing inhibitor concentrations were determined from the time courses by nonlinear 
regression using single exponential equations. The rate constants of inhibitor association 
and dissociation were determined by linear regression of the equation kobs versus inhibitor 
concentration. 
 
3.3.3 Results and discussion 
 
We performed 18 scaled MD simulations for each one of the 5 ligands selected 
(Figure 26). Runs were stopped once unbinding took place or if no detaching of the 
compounds was observed within a computational time of 100 ns. As we already stressed, 
no information about kinetics was available at this point. Moreover, the considered 
compounds presented the same scaffold and only minor chemical substitutions. Notably, 
such substituent groups did not introduce the possibility to accomplish any additional 
hydrogen bond nor salt bridges. Thus, we applied the methodology to a particularly 
challenging framework. The resolution of the procedure was tested in a real-life situation, 
that is exploiting computer simulations in a prospective manner with a choice of 
compounds that reflects a likely picture one might encounter during the optimization 
phase. As far as we know, such a scenario was not considered before. The unbinding times 
that we obtained were recorded and, according to the procedure followed in previous 
works, the corresponding average, median, standard deviation and standard error values 
were calculated over the 18 runs performed for each ligand. The results are reported in 
Table 3. 
As highlighted by the outcomes shown in the table, the ligands were characterized by 
considerably different average unbinding times, despite the small differences in their 
structures. In particular, ligand A9 was the fastest at leaving the binding site, while LIT 
was the slowest. 
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Ligand A9 A4 A7 A15 LIT 
Avg. (ns) 17.7 25.8 28.4 55.5 62.5 
Median (ns) 18 20.8 25.9 50 51.2 
St. Err. 3.2 4.3 4.2 8.1 6.4 
St. Dev. 13.4 18.2 17.7 34.2 27.2 
 
Table 3. Average, median, standard deviation and standard error obtained for the 5 ligands. The values were 
computed from the 18 scaled MD simulations performed for each ligand A9, A4, A7, A15 and LIT.  
 
At a more comprehensive glance, we could distinguish two major regimes. Ligands 
A9, A4 and A7 could be grouped together in a fast regime, while ligands A15 and LIT in a 
slow regime. The separation was justified by an increase of more than 25 ns in terms of 
average unbinding time. Notably, while the first group is characterized by ligands 
possessing methyl or ethyl substituents on the pyrrol, this is not the case for ligands A15 
and LIT. In other words, the hindrance caused by chemical groups on that side of the 
molecules, pointing towards the bottom of the binding pocket, is unfavorable for a tight 
binding of the active site, and causes ligands to detach faster. Notably, structure-activity 
relationship (SAR) carried out on scaffolds binding hDAAO reported in the literature 
suggested how the presence of bulkier substituents, such as methyl and ethyl groups, 
tended to reduce the activity of the compounds.145,146 Thus, our results were in line with 
known behavior for hDAAO inhibitors. Moreover, the observations also confirmed that the 
initial complexes that we reconstructed for the 5 ligands, for which no crystal structure was 
available, were reasonable. 
In our opinion, what was most informative was the qualitative interpretation of the 
unbinding simulations. Figure 29 shows the distribution of the computational unbinding 
times for each ligand. More than focusing on the values of average unbinding time, the 
aforementioned separation was what was clearest according to the Figure.  
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Figure 29. Distribution of the computational residence times. The counts for bins of 10 ns, from 0 to the 
maximum allowed value of 100 ns, are indicated on the y axis.  
 
Going from ligand A9 to LIT, there was a shift on the distributions, with a gradual 
reduction of the amount of fast unbinding events and an increase of slow ones. According 
to this picture, one would have definitely gathered precious indications on ligands to 
further optimize or to discard in a drug optimization context. 
Once the set of scaled MD simulations was completed, the compounds were purchased 
and assays to assess both activity and kinetic properties were carried out. The results are 
shown in Table 4. Unfortunately, despite ligand LIT was indicated as available for 
purchase, it was not possible to acquire it. Thus, we were able to carry out the experimental 
assays only for A9, A4, A7 and A15. Nevertheless, once purchase of the ligand LIT will be 
possible, we will integrate the results with the corresponding missing information. 
 
Ligand  IC50 (µM) Inactivation (%) Static Kd (µM) kon (µM/s) koff (1/s) Dynamic Kd (µM) 
A9 250.81 ± 23.31 50 - - - - 
A4 10.63 ± 0.91 total 5.65 ± 0.73 0.15 ± 0.01 1.11 ± 0.08 7.4 ± 0.72 
A7 14.5 ± 4.1 40 6.28 ± 0.71 0.12 ± 0.01 0.78 ± 0.08 6.5 ± 0.85 
A15 5.38 ± 0.26 total 12.91 ± 2.35 0.23 ± 0.01 0.66 ± 0.06 2.9 ± 0.28 
 
Table 4. Experimental data obtained from assays carried out on the 5 considered ligands. Uncertainties 
associated to the determined values are also indicated.  
 
Surprisingly, notwithstanding a very subtle difference between A9 and A7, no binding 
was observed for the former. We adduce such behavior to an increase in steric hindrance 
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when replacing a fluorine with a methyl group. As we already outlined, the size of the 
hDAAO active site is relatively limited. Thus, the protein appears to be very sensible in 
terms of dimensions for the ligands to host in the binding pocket.  
The trend of the koff values determined through the experiments was in agreement with 
the one expected basing on the scaled MD runs. In particular, predicted increasing 
residence times from the simulations corresponded to decreasing experimental koff values. 
The comparison is shown in Figure 30, where the correlation between simulations and 
experiments is reported.  
 
 
Figure 30. Computational versus experimental residence time. Values from both axes were normalized with 
respect to the slowest ligand A15; errors associated to the computational residence times, shown as error 
bars, were normalized as well, according to error propagation. Kinetic rates were subjected to exponential 
scaling according to the scaling factor adopted for performing the scaled MD simulations, that is 0.45. As no 
binding was reported for compound A9 in the assays, an arbitrary value was assigned; the choice was on one 
order of magnitude smaller than the dissociation rate constant determined for the slowest ligand. 
 
It is worth noticing that no clear-cut separation between A7 and A15, corresponding to 
the one observed in the predicted unbinding time values, was present in the experiments. 
Nevertheless, A15 was distinguished as the slowest ligand among the ones tested, in 
agreement with what determined through the scaled MD runs. Therefore, in the perspective 
of prioritizing ligands in terms of their residence times, the qualitative interpretation of the 
results from the simulations was able to provide strikingly relevant indications, in line with 
the experimental assays. In light of this, ligand A9 would have been undoubtedly discarded 
while ligand A15 preserved, during a hypothetic drug optimization campaign.  
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A characteristic structural feature of hDAAO is the presence of a loop at the entrance 
of the binding site, comprising residues 216 to 228.131 In the literature, it is typically 
referred to as the active-site lid.139,140 Most of the hDAAO ligands posses an aromatic, 
double-ring moiety that tends to place in the active site, specifically stacked in between of 
the FAD flavin ring and the side chain phenol from Tyr 224.145,147 Such configuration was 
already highlighted above and shown in Figure 27A. This stacked pi-pi scheme was 
observed in the bound state of several crystal complexes.148,149 In such configuration, 
access to the binding site is hindered. This is clearly shown in Figure 31, where a surface 
representation of the protein is given and the region to access the binding pocket is 
indicated.  
 
 
Figure 31. Focus on the active-site lid. The loop, comprising residues 216 to 228 (highlighted in red in the 
left hand panel), is located at the entrance of the binding site. In the central and right hand panels the protein 
is represent as vdW surface; in particular, the loop is intentionally not shown in the former. The comparison 
of the two surfaces highlights how the access to the ligand binding cavity is hindered by the presence of the 
active-site lid.  
 
hDAAO binding pocket has a relatively small volume, and this feature is confirmed by 
the typical small size of known inhibitors. However, ligands of greater dimensions able to 
inhibit the enzyme were subsequently discovered. The crystal structures for complexes 
with these ligands bound showed a more open state of the active site lid.139,149 This was 
necessarily related to the already mentioned small size of the pocket and to the binding 
pose of the inhibitors, that tend to direct one moiety towards the entrance of active site. 
Despites this behavior, no crystal structure with a completely open state for the active-site 
lid was reported up to this date. Moreover, while the possible involvement of this loop in 
ligand binding has been long proposed and argued,139,140 no systematic characterization 
was carried out.  
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As we carried out unbinding simulations, we observed the active-site lid behavior in 
our scaled MD runs. As outline above, no position restraints were applied to the loop. 
Thus, this was able to rearrange and respond to ligand unbinding. We stress that, as already 
mentioned, transitions along all of the degrees of freedom of the system are significantly 
enhanced under scaled MD conditions. In other words, we had no means to assess that the 
observed active-site lid behavior reflected the real dynamics that would be recorded under 
plain MD conditions. This is particularly true as observing spontaneous unbinding (and 
also binding) in such a scenario, with a salt bridge, hydrogen bonds and pi-stacking 
stabilizing the bound state, and the binding site entrance closed by the loop, would likely 
require extremely long plain MD simulations. Nevertheless, we monitored the overall 
stability of the protein and the behavior of the loop by carrying out 3 plain MD simulations 
with no ligands in the binding site. In particular, as the active form of the enzyme is a 
homodimer,131 we performed two 100 ns-long run for the monomer, and one 100 ns-long 
run for the dimer. The Root Mean Square Fluctuation (RMSF) on the a-carbons was 
calculated to observe mean fluctuations, and is shown in Figure 32.  
 
 
Figure 32. RMSF for the monomer in the plain MD runs. Four curves are shown, two corresponding to 100 
ns-long simulations for the monomer, and two from the monomers present in the homodimer, for which one 
100 ns long run was performed. The grey and white fingerprint in the background highlights structured, 
namely a-helices and b-sheets, and loop regions, respectively. 
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As it can be seen, beside high values for residues 295-305 that are comprised in a fully 
solvated loop located at a significant distance from the binding site, all of the runs 
demonstrated higher RMSF for residues 216-228. Despite no active-site lid 
opening/closure event was observed in the aggregated 400 ns of plain MD simulations for 
the monomer, this is undoubtedly an evidence of intrinsic flexibility for the active site 
loop.  
Focusing on the active-site lid in the scaled MD runs during the unbinding process, we 
notice two major behaviors, to which we refer as pathway A and pathway B. In pathway A, 
Tyr 224 is fully solvated before the ligand is able to leave the active site. Whit the loop 
opened in such configuration, the entrance to the cavity is not hindered anymore and water 
molecules are able to access. This in turn facilitates the ligand detachment and unbinding 
takes place. Contrarily, when pathway B is followed, Tyr 224 points towards the binding 
pocket and is bent towards the base of the site. While the change with respect to the initial 
configuration is not as drastic as in pathway A, the cavity is also more accessible as a 
result. Thus, the ligand is able to squeeze through the available volume that connects with 
the bulk, once the stable interactions with protein residues are broken. To monitor the two 
possible cases, we calculated the distance between Tyr 224 and the binding site centers of 
mass as a function of the simulation time. Sample runs with unbinding in pathway A or 
pathway B are shown in Figure 33.  
 
 
Figure 33. Sample pathways A (left panel) and B (right panel) during unbinding, respectively taken from 
scaled MD runs 15 and 16 on ligand A15. The ligand-pocket distance is shown on the x axis to assess 
unbinding. The values on the y axis was exploited to determined which of the two pathways was followed. In 
particular, a cut-off value of 10 Å (1 nm in the plots) was used to distinguish the two cases.  
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The frequency with which the two possible pathways were followed over the 18 scaled 
MD runs was registered for each one of the 5 ligands considered. The results are shown in 
Figure 34.  
 
 
Figure 34. Classification of the unbinding events according to the path followed by the active-site lid, 
namely pathway A or pathway B. The corresponding bars are coloured basing on the simulation time of the 
unbinding events. 
 
At a first glance, it is clear immediately that, in the vast majority of the cases, the 
pathway A was preferred. In other words, the opening of the lid was the limiting, necessary 
condition to allow the small molecules for jumping into the bulk. Notwithstanding the 
lower frequency with which the pathway B was followed, it is undoubtedly interesting 
observing that all of the ligands were able to access it. One relevant aspect arising is the 
different timescales related to the two paths. Notably, when pathway B was followed, 
unbinding was generally faster. Thus, while this route was less likely in our scaled MD 
simulations, it also required less time. Conversely, pathway A resulted as more likely, but 
longer times were involved to reach unbinding. We stress again that little can be concluded 
about the active-site lid behavior, as not enough statistics was gathered in the first place, 
and also because of the significantly smoothed potential energy surface due to the l factor 
applied. Nevertheless, our observations were in line with a potential involvement of the 
loop in ligand binding/unbinding, and also suggested possible mechanisms. Certainly, 
assessing the real dynamics would require additional, and specifically devised, simulations 
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and possibly experiments. From such perspective, our observations might provide a useful 
starting point.  
 
3.3.4 Conclusions 
 
It is doubtless that residence time has gained significant relevance in drug discovery.10 
Thus, being able to improve kinetic properties during the drug optimization phase would 
be extremely desirable. For instance, devising inhibitors that give prolonged binding would 
extend the duration of the pharmacological effect, a particularly important point when this 
represents a large component of in vivo activity.5 Within this framework, a computational 
approach based on enhanced sampling was recently developed to prioritize ligands 
according to their residence time.21 Based on scaled MD, it relies on simulating several 
unbinding events for series of small molecules presenting a common scaffold. The average 
time necessary for unbinding is then calculated from the scaled MD runs for each ligand. 
The idea is to be able to discriminate between fast and slow binders, thus offering guidance 
in terms of kinetic properties during the optimization phase. In this study, we applied the 
procedure to a series of small molecules binding to hDAAO. The ligands, all possessing 
the same scaffold, were characterized by subtle modifications in term of substituent 
groups. Without any a priori knowledge about their residence time, we ranked these 
ligands according to the computational unbinding times. Subsequently, we performed 
assays to determine experimental off rates and the corresponding residence times. The 
correlation that we obtained was very satisfactory. Besides being able to distinguish 
between fast and slow binders, the ranking obtained through the computational procedure 
was confirmed by the experiments. Moreover, we investigated the scaled MD trajectories 
to possibly extract information about molecular features related to the unbinding process. 
Thus, we recognized two main conformations in which the active-site lid, located at the 
entrance of the binding pocket,139,140 can be found during ligand unbinding. Despite no real 
quantification was achieved, this undoubtedly provided interesting indications that could 
be examined more thoroughly by subsequent studies.  
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3.4 AUTHOR CONTRIBUTION 
 
The PhD candidate contributed substantially to all of the three applications presented 
herein. In particular, as for test case 1, namely NTAIL, he performed the MetaD simulations 
and the analysis thereof. Additionally, he worked on the construction of the kinetic model 
proposed for the peptide. Concerning the second test case, that is the b2-AR complexed 
with the ligand Alprenolol, the candidate constructed the MSM starting from already 
available MD trajectories, performed the steered MD simulations, and built the guess path 
for the protein-ligand binding process. Finally, he carried out the scaled MD simulations 
on the third test case, hDAAO. All of the analysis of the produced trajectories, including 
the estimation of the computational unbinding times and the investigation about the active 
site lid behavior during ligand unbinding, were accomplished by the PhD candidate. 
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4. CONCLUSIVE REMARKS AND PERSPECTIVES  
 
A comprehensive analysis of both structural and dynamical aspects pertaining to 
relevant biological systems demands for the inclusion of kinetics, alongside 
thermodynamics. In this dissertation, we explored possible strategies based on current, 
state-of-the-art computational techniques to achieve this end. We devised different 
protocols according to the specific biomolecular system and to the particular scientific 
question that we were interested in addressing. In all of the cases presented, despite 
recognized limitations, computational approaches proved to be effective and reliable tools 
for the considered purposes. 
We showed that enhanced sampling, and in this specific case MetaD, can be exploited 
to characterize the highly heterogeneous configurational space accessible to an intrinsically 
disordered protein. The procedure was applied to NTAIL, a test case IDP. In this particular 
context, force field represented indeed a more evident limitation than sampling itself. 
Although details about the timescales at which events take place are lost when employing 
enhanced sampling, we backtracked this information by constructing a kinetic model based 
on a binning strategy of the free energy. As a result, it was possible to estimate both 
thermodynamic and kinetic equilibrium properties of NTAIL, achieving results in good 
agreement with available experimental data. The study clearly demonstrated how the 
proposed strategy is already approachable by means of current hardware and software 
architectures. The limiting steps are the reconstruction of a detailed and reliable FES and 
the determination of a diffusion matrix. Since the latter can be relatively easily obtained 
from multiple, short and not necessarily converged plain MD simulations, the former goal 
represents the major challenge. Undoubtedly, achieving a comprehensive and statistically 
relevant exploration of a configurational space is a more general matter in structural 
biology, that extends beyond the specific problem addressed in this dissertation. We dealt 
here with a single solute molecule possessing a highly heterogeneous conformational 
space. While systems of similar molecular size and complexity can be already addressed, 
even more challenging scenarios could be considered in the future, such as protein-protein 
or protein-ligand association. Therefore, as long as the FES related to specific processes of 
interest can be accurately reconstructed, the proposed procedure holds great potential in 
elucidating the underlying kinetics.  
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Unveiling the molecular features associated with protein-ligand binding would provide 
a striking support to the optimization of potential, novel drug-like molecules. 
Unfortunately, from a computational standpoint, achieving such detailed description with 
statistical significance is extremely onerous. In this context, we aimed at reconstructing the 
free energy surface for the binding process of the well-known inhibitor Alprenolol to the 
b2-AR. We constructed a Markov State Model taking advantage of long-timescale plain 
MD simulations to spot the relevant states along the binding route. MSM are typically 
constructed from plain MD trajectories, through count of the transitions between the 
different microstates in which the system can be found Thus, the model allows identifying 
the timescales associated with such transitions and predicting longer timescales kinetics. 
Notwithstanding the possibility of aggregating multiple, shorter, independent trajectories, 
that has increased significantly the appealing of such method, the demand in terms of 
sampling is still remarkable. Indeed, gathering appropriate statistics for each microstate, 
which is an essential requirement for the estimation of a reliable transition probability 
matrix, is currently the major challenge. In the case we faced herein, tens of microseconds 
were necessary to capture few spontaneous binding events. Notably, no unbinding nor 
rebinding were observed, making the information even more limited. Despites providing 
precious indications about the molecular features involved, these were not statistically 
meaningful. As such, we employed the data to build a non-reversible MSM from which 
determining the relevant states along the binding route. Basing on this information, we 
were able to reconstruct a putative pathway going from the protein surface to the 
orthosteric binding site, that will be subsequently exploited to perform path CV-based 
MetaD in order to determine the free energy surface associated with the process. In 
particular, energy barriers between metastable states could be ultimately determined and 
kinetic rates computed, achieving a level of characterization that is typically not accessible 
to experiments. While the proposed procedure can be successful, it is extremely case-
dependent and applicable to one to few systems, considering the effort involved. 
Nevertheless, in light of the advances in computer power observed during the recent years, 
it is reasonable to expect that gathering sufficient statistics for complex processes via plain 
MD will be increasingly feasible. This, in turn, will allow constructing reliable MSM from 
which extracting kinetic information directly. Furthermore, recent theoretical advances are 
demonstrating the possibility of exploiting enhanced methods as a source of sampling for 
MSM construction, considerably accelerating the possibility of retrieving kinetics from 
molecular simulations. 
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Real life scenarios in drug discovery and development programs demand for practical, 
effective and relatively fast solutions, possibly applicable to a bunch of drug-like 
molecules. Both academia and mostly industry are gradually including protocols to 
evaluate kinetic parameters in the ligand optimization stages. However, from a 
computational standpoint, due to the complex, system-specific setup and the significant 
computational effort involved, achieving a detailed characterization of molecular 
determinants and the estimation of kinetic parameters in a routinely manner is not feasible 
yet. Nevertheless, strategies are emerging aiming at fulfilling such demand. We applied a 
recent procedure based on prioritization of ligands according to their relative residence 
times determined through unbinding simulations carried out via scaled MD. Specifically, 
we considered a series of congeneric ligand of hDAAO bearing subtle structural 
differences. Without any a priori information about their kinetic profiles, we showed that 
the obtained prioritization reflected the subsequently determined experimental kinetic data. 
The present application along with previous studies are demonstrating that the strategy is 
able to rank ligands in agreement with experiments. Assessing this consensus represents a 
crucial, necessary step towards the utilization of these simulations as a reliable, 
independent tool. From a drug discovery standpoint, the ability of discriminating faster and 
slower ligands is undoubtedly of great interest. Being able to prioritize those ligands 
possessing the desired kinetic features for further optimization would be of remarkable 
support. Despite being a promising picture, the computational effort involved is still not 
negligible. For instance, in the present case, where five ligands were examined, the 
protocol led to production of an amount of trajectories in the order of hundreds of 
nanoseconds. However, as already stressed, few to no binding events would be observed 
via plain MD for a single ligand within such simulation lengths. While the strategy is 
already emerging as a promising tool, the possibility of handling larger sets of compounds 
will express its real potential in the drug discovery pipeline. Future developments of 
current hardware and software architectures will be the major determinants towards this 
goal. In a more focused perspective, more gentle scaling factors could be also explored on 
representative ligands. Once an appropriate space is envisaged on which attempting a 
reweighting procedure, the underlying FES can be reconstructed and precious insights 
gained into the energetics and kinetics associated with the binding event. Notably, the 
latter scheme can find broader applications besides protein-ligand binding, including 
conformational changes and protein-protein association.  
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As a final remark, we can distinguish two main pictures arising from our studies. On 
the one side, more demanding computational protocols can be applied when particularly 
challenging scenarios need to be tackled, and specific questions need to be addressed. 
Although this does not configure well within routinely applicable procedures, it 
nevertheless represents a precious resource. On the other side, real life challenges require 
juggling multiple ligands and possibly multiple pharmacological targets. Therefore, 
computational chemistry strategies that are relatively easy to apply, and that involve 
contained computational resources, are starting to gain attention. Notwithstanding a 
possibly questionable accuracy in single, specific cases, an overall effectiveness when 
dealing with large numbers and aiming at a gross selection would nevertheless be a 
significant achievement. 
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